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Abstract
The equilibrium between energy consumption and energy production defines the metabolic rate of an
organism. This homeostatic balance is tightly regulated by a variety of sophisticated processes that
occur within and between cells and tissues. These processes also allow animals to tolerate some
deviation from baseline by recruiting adaptive mechanisms to bring cells and organisms back to
homeostasis. Temporary changes in the organism’s environment, such as alterations in ambient
temperature, oxygen levels and infections are examples of conditions where animals must have a
healthful adaptive metabolic response, allowing them to sustain the duration of the stress. However, in
conditions of chronic disease or long-term stress, these adaptive mechanisms can no longer be
protective and may even contribute to the damage incurred by the animal. Therefore, metabolism can
either be healthful and adaptive to stressors, or stressors can induce pathogenic metabolic changes in an
organism. In this body of work, I explore this bidirectional relationship between external stresses and
organismal metabolism. In chapter 2, I investigate the contribution of hypermetabolism (energy
production > energy consumption) in a mouse model of the disease amyotrophic lateral sclerosis (ALS).
While hypermetabolism is a feature of ALS, it is not known if it contributes to disease pathogenesis. In a
mouse model of ALS, I genetically induce hypometabolism to determine if this change alters disease
progression. In chapter 3, I study the role of neuropeptides in regulating hypometabolic tolerance to
extreme oxygen deprivation. Here, I employ C. elegans, a genetically tractable soil-dwelling nematode, as
a model. Worms can tolerate long durations of anoxia by lowering their metabolic rate, and loss of
neuropeptide signaling can further increase its ability to tolerate this stress. I investigate various aspects
of neuropeptide regulation of this phenotype. Together, these projects demonstrate the role of
metabolism in health, disease and stress, and suggest that inter-cellular and inter-tissue communication
is a critical aspect of metabolic homeostasis.
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ABSTRACT
GENETIC REGULATORS OF TOXICITY IN A MOUSE MODEL OF AMYOTROPHIC
LATERAL SCLEROSIS AND A WORM MODEL OF ANOXIC INJURY
Shachee Doshi
Robert G. Kalb

The equilibrium between energy consumption and energy production defines the
metabolic rate of an organism. This homeostatic balance is tightly regulated by a variety
of sophisticated processes that occur within and between cells and tissues. These
processes also allow animals to tolerate some deviation from baseline by recruiting
adaptive mechanisms to bring cells and organisms back to homeostasis. Temporary
changes in the organism’s environment, such as alterations in ambient temperature,
oxygen levels and infections are examples of conditions where animals must have a
healthful adaptive metabolic response, allowing them to sustain the duration of the
stress. However, in conditions of chronic disease or long-term stress, these adaptive
mechanisms can no longer be protective and may even contribute to the damage
incurred by the animal. Therefore, metabolism can either be healthful and adaptive to
stressors, or stressors can induce pathogenic metabolic changes in an organism. In this
body of work, I explore this bidirectional relationship between external stresses and
organismal metabolism. In chapter 2, I investigate the contribution of hypermetabolism
(energy production > energy consumption) in a mouse model of the disease amyotrophic
lateral sclerosis (ALS). While hypermetabolism is a feature of ALS, it is not known if it
contributes to disease pathogenesis. In a mouse model of ALS, I genetically induce
hypometabolism to determine if this change alters disease progression. In chapter 3, I
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study the role of neuropeptides in regulating hypometabolic tolerance to extreme oxygen
deprivation. Here, I employ C. elegans, a genetically tractable soil-dwelling nematode,
as a model. Worms can tolerate long durations of anoxia by lowering their metabolic
rate, and loss of neuropeptide signaling can further increase its ability to tolerate this
stress. I investigate various aspects of neuropeptide regulation of this phenotype.
Together, these projects demonstrate the role of metabolism in health, disease and
stress, and suggest that inter-cellular and inter-tissue communication is a critical aspect
of metabolic homeostasis.
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CHAPTER 1

General Introduction

Metabolic homeostasis is essential to health and physiology. It operates at
cellular and organismal levels to coordinate and balance energy intake and expenditure.
However, it can deviate from this homeostatic balance in conditions of stress and
disease. Here, I will explore two different contexts of metabolism - one in which
metabolic adaptation is detrimental to a particular neurodegenerative disease, and
another in which metabolic adaptation is essential to survival against an environmental
stress.

Metabolic dysfunction at the organism level is a feature of many
neurodegenerative diseases such as Alzheimer’s disease (AD), Amyotrophic lateral
sclerosis (ALS), Huntington’s disease (HD) and Parkinson’s disease (PD) (Dupuis et al.,
2011; Cai et al., 2012). These changes are not identical across these diseases, but it is
interesting to note that many of the same markers such as circulating hormones and
body weight are commonly altered in all of them. A brief outline of these abnormalities
follows below.
In Alzheimer’s disease, the most widely occurring neurodegenerative disease
and the leading cause of dementia and cognitive impairment, increased body weight in
midlife (35-65 years) has a significant correlation with onset of dementia in later life
(Albanese et al., 2017). Type 2 diabetes is strongly correlated with AD, brain glucose
metabolism is decreased in patients with AD compared to controls, and abnormalities in
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glucose metabolism manifest decades before cognitive symptoms of AD (Mosconi,
2005; Chen and Zhong, 2013; Duran-Aniotz and Hetz, 2016). AD patients can manifest
neuronal insulin resistance and have increased brain insulin receptor expression (Frölich
et al., 1998; Stanley et al., 2016). Metabolic hormones such as leptin and ghrelin are
also altered in AD – higher circulating leptin correlates with higher brain volume and
reduced incidence of dementia and AD while ghrelin mRNA is decreased in cortex of AD
patients (Lieb et al., 2009; Gahete et al., 2010).
HD patients have increased weight loss and increased fasting energy
expenditure than controls (Pratley et al., 2000; Aziz et al., 2010). Patients also have
increased leptin secretion with increased CAG repeat length (Ahmad Aziz et al., 2009).
Total cholesterol, high density lipoprotein and low density lipoprotein levels are all
decreased in HD patients compared to familial controls (Wang et al., 2014).
In PD, patients have increased serum levels of insulin-like growth factor 1
compared to healthy controls (Godau et al., 2010). Patients also demonstrate decreased
body weight (Chen et al., 2003), and patients with decreased weight loss also have an
unrelated decrease in circulating leptin (Evidente et al., 2001).
ALS patients also present with a hypermetabolic phenotype, measured as a
higher resting energy expenditure, that manifests early, is persistent and is correlated
with survival (Desport et al., 2001; Bouteloup et al., 2009; Funalot et al., 2009a). A
higher premorbid BMI and higher fat diets are associated with better disease
progression in ALS (Ngo et al., 2014). Patients have impaired glucose tolerance (Pradat
et al., 2010), and the level of total cholesterol is two-fold higher in ALS patients
compared to controls (Dupuis et al., 2008).
While there is a growing body of work highlighting a wide range of organism level
deficits in metabolic homeostasis in neurodegenerative diseases, it is unknown if this
2

altered metabolic state contributes to worsening disease progression. It is, therefore,
important to gain a deeper understanding of how perturbations in metabolic homeostasis
contributes to the progression of various neurodegenerative diseases in order to devise
effective treatment plans. In the current work, we focus on ALS to highlight and address
whole organism metabolic changes observed in this disease.

Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, Charcot
disease and motor neuron disease, is a devastating neurodegenerative disease
characterized by progressive loss of upper and lower motor neurons leading to muscle
wasting, paralysis and ultimately death due to respiratory failure. It has a worldwide
incidence of 1.9 in every 100,000 people (Arthur et al., 2016), and affects more men
than women. It is also more prevalent in non-Hispanic populations, and affects military
veterans and sports people at a higher rate than the rest of the population (Hardiman et
al., 2011; Kiernan et al., 2011). ALS is the most common adult onset motor neuron
disease, with an average age of onset around 55-60 (Ferraiuolo et al., 2011). It
progresses rapidly, and most patients die within 3-5 years of symptom onset. In addition
to motor symptoms, a subpopulation of patients also manifests deficits in cognitive
functions such as decision-making and language processing (Phukan et al., 2007). As a
result, ALS has significant clinical and biological overlap with frontotemporal dementia,
and the two are thought to be on a pathophysiological continuum (Ling et al., 2013). Ling
et al carefully describe the clinical features that set up the ALS-FTD spectrum as well as
underlying genes and molecular mechanisms that may regulate ALS-FTD. For example,
mutations in some genes such as SOD1 and TDP-43 are thought to predominantly result
in ALS, while others in VCP and Tau are predominant in causing FTD, and still others
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like C9orf72 can cause either ALS or FTD or both. It is expected that the number of
people living with ALS will increase from 222,801 in 2015 to 376,674 in 2040,
representing an increase of 69% (Arthur et al., 2016), and the disease will thus place a
significant economic burden on society. There is currently no cure for the disease and
Riluzole, one of two drugs approved for treatment of ALS, provides a very modest
improvement in patient outcome (Renton et al., 2014). The FDA approved a second
drug, Radicava, earlier this year, 22 years after Riluzole. However, it too, was only able
to slow symptoms in a 6-month clinical trial without significantly altering disease course
(Hardiman and van den Berg, 2017).
The majority of ALS cases are sporadic (sALS), with no known single genetic
abnormality but 5-10% of cases are familial (fALS) and result from single gene mutations
with a family history of the disease (Ferraiuolo et al., 2011). The most common genetic
cause of fALS is C9orf72, and the pathogenic expansion of a hexanucleotide repeat in
the gene accounts for 25-40% of familial cases (Allen et al., 2014; Tan et al., 2014).
While the exact function of the native protein encoded by the C9orf72 locus remains
unclear, the disease-associated allele of C9orf72 (containing the GGGGCC repeat
expansion) disrupts many aspects of cellular function. Cells with expanded C9orf72 have
RNA accumulations in the nucleus with improper RNA processing and mis-splicing
(Prudencio et al., 2015) and dysfunctional trafficking between the nucleus and cytoplasm
(Zhang et al., 2015).
The second most common causative gene in fALS is the Cu/Zn superoxide
dismutase 1 (SOD1), accounting for 12-20% of familial cases (Renton et al., 2014).
SOD1 is a cytosolic enzyme and is responsible for scavenging free radicals and
converting superoxide to hydrogen peroxide. A large number of point mutations (>100)
in SOD1 have been associated with ALS, and these mutations cause a toxic gain of
4

function in the enzyme, which leads to pathology (Mattiazzi, 2002; Lin and Beal, 2006).
Mutations in TAR DNA-binding protein of 43kDa molecular weight (TDP-43), fused in
sarcoma (FUS), optineurin (OPTN), valosin-containing protein (VCP), among others, are
also known to cause fALS (Ferraiuolo et al., 2011; Renton et al., 2014).
Generally, patients with fALS have an earlier age of onset than those with sALS,
however, disease progression and pathological features of sALS and fALS share
commonalities (Kiernan et al., 2011; Ngo et al., 2014). The most widely used mouse
models of the disease are based on fALS-linked mutations in SOD1 and TDP-43. These
models share many of the features of the disease, including death of motor neurons,
muscle wasting, limb paralysis and short lifespan (Picher-Martel et al., 2016). Studies in
these models of disease have revealed many cellular features and pathogenic
characteristics associated with disease progression. Some of these include dysregulated
RNA metabolism/trafficking, endoplasmic reticulum (ER) stress, oxidative stress, protein
misfolding and aggregation, autophagy, mitochondrial dysfunction, impaired axonal
transport and inflammation (Tefera and Borges, 2017). Adding to this list is a growing
body of work implicating the role of altered metabolism to ALS pathophysiology.

Metabolic dysfunction in ALS
Studies in ALS patients and animal models have revealed a range of organismlevel and cellular metabolic abnormalities, some of which are highlighted below:
(i) ALS patients and mouse models display hypermetabolism, a state in which energy
expended by the organism is greater than the energy consumed (Dupuis et al., 2004;
Bouteloup et al., 2009; Dupuis et al., 2011; Ngo et al., 2014). There is a 20% increase in
resting energy expenditure measured by indirect calorimetry in a significant
subpopulation (48%) of ALS patients, even after normalizing for fat-free mass
5

(Bouteloup et al., 2009). In a small study, 100% of patients with fALS were
hypermetabolic, as compared to 52% of sALS patients (Funalot et al., 2009a).
(ii) There is a strong correlation between premorbid BMI and ALS risk. Patients with low
BMI have decreased survival compared to those with higher BMI (Jawaid et al., 2010a).
Additionally, individuals with higher BMI (overweight or obese) earlier in life had a lower
risk of developing ALS. There was a 21% decrease in rate of ALS with every 5-unit
increase in BMI (O'Reilly et al., 2013).
(iii) ALS patients display dyslipidemia, where the ratio of low density lipoproteins (LDL) to
high density lipoproteins (HDL) is high (Dupuis et al., 2008; Jawaid et al., 2010b).
(iv) ALS patients present with a higher prevalence of hyperglycemia and glucose
intolerance compared to healthy controls. Additionally, ALS patients and mouse models
have lower glucose uptake in certain regions of the brain and the spinal cord (Miyazaki
et al., 2012; Cistaro et al., 2014). This demonstrates impaired glucose metabolism in
patients and animal models of ALS.
(v) ALS patients and mouse models have mitochondrial dysfunction. Motor neurons from
patient spinal cords display morphologically abnormal mitochondria, appearing
aggregated, swollen and vacuolated (Sasaki and Iwata, 2007). Similarly, SOD1 and
TDP-43 mouse models of ALS are also similar in their morphology (Magrané et al.,
2014; Stribl et al., 2014). In addition, mitochondrial function is compromised in ALS as
evidenced by decreased electron transport chain activity and decreased ATP production
in spinal cords from patients and animal models (Mattiazzi, 2002; Wiedemann et al.,
2002; Kirkinezos et al., 2005). The work in mice shows that these mitochondrial
abnormalities present earlier than motor symptoms, and may indicate a role for cellular
energy dysfunction in disease pathophysiology.
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Together, these data indicate significant perturbations in organism-wide as well
as cellular changes in metabolism associated with ALS. Is organismal metabolic
dysfunction a result of underlying cellular pathology in ALS, or does it contribute to
causing disease pathology? If the latter is true, these metabolic parameters could be
potential therapeutic targets to alter course of disease. Data from mouse studies suggest
that the latter may be true. For example, mitochondrial dysfunction as well as altered
expression of lipid metabolism genes occurs at presymptomatic stages in ALS
(Ferraiuolo et al., 2011). Certain dietary interventions, all involving different types of high
caloric diets have benefited mutant SOD1 mice (Dupuis et al., 2004; Zhao et al., 2006;
Ari et al., 2014). In patients, similar dietary manipulations have also proven successful,
albeit the size of the study was small. Patients fed a high carbohydrate, high calorie diet
had an increased lifespan with delayed weight loss and fewer adverse events compared
with patients fed a regular diet (Wills et al., 2014a). These studies indirectly suggest that
metabolic dysfunction, specifically hypermetabolism, could be a targeted for therapeutic
intervention in ALS. However, the question that remains is whether directly altering
metabolic dysfunction can be beneficial to disease progression.
Previous studies from our lab have also tried to address hypermetabolism in
SOD1 mice bearing the G93A point mutation by genetically inducing a lower metabolic
state (Lim et al., 2014). This was achieved by generating G93A mutant SOD1 mice that
had a deficiency in the leptin hormone. Leptin is a circulating hormone released by
adipocytes. It crosses the blood brain barrier and acts on leptin receptors in the
hypothalamus to suppress hunger and appetite. Leptin deficient animals are obese and
hypometabolic, as they are worse at suppressing hunger and inducing satiety. In their
study, Lim et al found that in agreement with the literature, G93A SOD1 single mutant
mice were hypermetabolic. Leptin deficient (ob/+) single mutant mice, on the other hand,
7

were overweight and hypometabolic. G93A SOD1 and ob/+ double mutant mice mimic
the weight gain and hypometabolic phenotype of ob/+ mice, demonstrating that
genetically altering leptin levels is sufficient to alter the hypermetabolism of G93A SOD1
animals. Interestingly, the double mutant mice had improved limb strength and a female
specific increase in median lifespan compared to G93A SOD1 mice alone. This indicates
that hypermetabolism contributes to ALS pathophysiology in the G93A SOD1 mouse
model.
Since leptin is a circulating hormone, it has functions in the periphery as well as
the brain. Additionally, there is emerging evidence for non-hypothalamic actions of leptin
in the brain (Ahima et al., 1999; Figlewicz et al., 2006; Van Doorn et al., 2017). This
raises a few questions: 1) does leptin act on its receptor targets in the hypothalamus to
achieve this benefit, or are its peripheral targets also important? 2) since heterozygous
leptin deficient mice showed improvement in the G93A SOD1 background, could
stronger hypometabolism be even more beneficial in this model? To answer these, we
focused our studies on deletion of the melanocortin-4 receptor (MC4R), a downstream
target of leptin in the arcuate nucleus of the hypothalamus. If leptin acts on the
hypothalamus for its hypometabolic benefit in G93A SOD1 mice, MC4R should mimic
leptin’s effects in the G93A SOD1 mouse, and enhance the effect because it is a
complete null rather than a heterozygote. We hypothesized that loss of MC4R would
induce hypometabolism and increase motor output and survival in G93A SOD1 mice.
This work is detailed in chapter 2 of my dissertation.

Metabolic adaptation to adverse environmental stresses
ALS serves as an example that lowering metabolic rate can be neuroprotective in
certain neurodegenerative diseases where hypermetabolism is a feature of disease. In
8

certain acute injuries and stresses, lowering metabolic rate by therapeutic hypothermia
is also neuroprotective. In the clinic, therapeutic hypothermia is used to treat patients
with cardiac arrest and in newborn infants with hypoxic ischemic encephalopathy to
prevent resultant anoxic brain damage (Nagel et al., 2014). It is also being tested as a
therapy for other acute conditions such as traumatic brain injury and stroke (Han et al.,
2015). In therapeutic hypothermia, the core body temperature is reduced from 37°C to
32-35°C (mild), 25-32°C (moderate) or < 25°C (severe/deep) (Lyden et al., 2006). While
the exact mechanism for the neuroprotective effects of hypothermia remain murky,
lowering metabolic rate in cells helps to prevent the inflammatory response and resulting
apoptosis or necrosis in neurons.
Despite the potential neuroprotective benefits of lowering metabolic rate in
certain cases of disease and acute injury/trauma, humans (and many other mammals)
do not generally alter their metabolic rate physiologically in response to disease, injury,
or environmental stress. Many other species, however, have evolved hypometabolic
mechanisms to adapt to environmental stresses such as extreme temperatures and low
oxygen levels. A large number of birds and mammals hibernate to conserve energy
during winter months. The western jumping mouse can hibernate for upto 9 months of
the year, and edible dormice can hibernate upto 11 months in years they are nonreproductive (Cranford, 1983; Hoelzl et al., 2015). During hibernation, animals suspend
feeding, locomotion and reproduction. This is achieved by lowering metabolic rate
leading to slow breathing, decreased heart rate and lower core temperature. Seasonal
hibernation can thus help animals reduce energy expenditure by as much as 85% (Dark,
2005). Some animals enter a state of torpor where they decrease energy utilization on
shorter timescales – hours or days Hummingbirds can lower their core temperature and
9

metabolic rate during the night (Hargrove, 2005). Similarly, when oxygen availability is
reduced, many animals adapt by lowering their metabolic rate. Worms, flies, zebrafish,
turtles and even mammals, such as the naked mole-rat, are able to survive extreme
oxygen deprivation (anoxia) by reducing metabolic demand (Ultsch and Jackson, 1982;
Krishnan et al., 1997; Van Voorhies and Ward, 2000; Padilla and Roth, 2001; Park et al.,
2017).
Humans too adapt to certain environmental stresses on the evolutionary timescale.
For example, populations of people that live in high altitude regions such as Tibet have
differentially expressed genes in order to efficiently utilize limited oxygen in that
environment (Simonson et al., 2010). They have a normal metabolic rate despite severe
arterial hypoxia, potentially representing an adaptation to extreme environments over
thousands of years. The authors found genes in the hypoxia-inducible factor signaling
pathway such as EGLN1, EPAS1 and PPARA were positively selected in Tibetan
highlanders. Additionally, high altitude-dwelling Tibetans with lower levels of hemoglobin
also have increased cardiac output and greater exercise capacity (Simonson et al.,
2015).
These adaptive advantages are present in select human groups because they
evolved over long timescales. Therefore, not all humans can adopt these strategies to
survive environmental stresses on the order of days or months. Many mammals,
however, including primates like the Madagascan lemur, can hibernate to adapt to
environmental stressors (Dausmann et al., 2004). The western painted turtle survives
oxygen deprivation and freezing temperatures, and has many differentially expressing
genes in anoxia that have human orthologs such as the glucose transporter GLUT1 and
an apolipoprotein encoding gene APOLD1, among others (Shaffer et al., 2013). Studying
metabolic adaptations in these animals can thus be utilized to understand if similar
10

changes would benefit humans, who have similar genes and molecular pathways, when
challenged with similar environmental stresses. Gaining a better understanding of
adaptations to environmental stresses can also have potential benefits for acute injuryrelated challenges or chronic challenges such as space travel. In fact, NASA is studying
torpor to allow humans to survive long journeys in space (www.nasa.gov).
Then nematode Caenorhabditis elegans (C. elegans) is a great animal model to
study response and adaptation to changes in environment (described in detail below). In
chapter 3 of my dissertation, I will describe work in C. elegans to focus on severe
oxygen deprivation (anoxia) as one such environmental stress. The goal of my project
was to expand on previous data from our lab and specifically explain how neuropeptide
signaling regulates the worm response to anoxia.

Oxygen deprivation in C. elegans – hypoxia vs. anoxia
C. elegans is a 1mm long, transparent nematode that normally dwells in soil and
rotting vegetable matter. It was established as a powerful organism by Sydney Brenner a
few decades ago (Brenner, 1974) and has since been used to study genetics, cell
biology, circuit function and basic behaviors. It feeds on bacteria and is easily cultivated
in the lab on agar plates seeded with a lawn of the E. coli strain OP50, although other
strains of feeding bacteria are used depending on the study question. There are many
advantages to studying worms as a model organism. C. elegans has a short life cycle –
it grows from egg to adulthood in 3 days when raised at 20°C, and lives for 2-3 weeks,
so experiments can be done relatively rapidly. It is primarily a self-fertilizing
hermaphrodite and each animal can lay upto 300 eggs, allowing for high throughput
experiments. It is transparent, allowing for ease of microscopy and use of fluorescent
genetic markers. Its anatomy is well studied – it has exactly 959 somatic cells and 302
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neurons and its neuronal wiring diagram is known. Its genome has been sequenced and
a large number of C. elegans genes have homology with mammals and even humans
(www.wormbook.org).
Since they live in the soil and rotting fruit, worms frequently encounter oxygendepleted microenvironments in their natural habitat and can tolerate low oxygen well.
They generally prefer 5-12% O2 environments (Gray et al., 2004) but are able to survive
hypoxia (<0.5 - 1% O2) without altering feeding, locomotion or reproduction (Nystul et al.,
2003; Miller and Roth, 2009). This requires the activation of the hypoxia induced
transcription factor hif-1 and its downstream gene targets. Their response to anoxia
(<0.1% O2), however, is markedly different and is hif-1-independent (Padilla et al., 2002;
Ghose et al., 2013). In anoxia, animals enter a reversible state of ‘suspended animation’
in which they cease all movement, feeding and reproduction. Larvae and young adults
can tolerate 24 hours of suspended animation under anoxia at 20°C, but lethality
increases with increasing temperature and increasing duration of anoxia exposure (Scott
et al., 2002; Mendenhall et al., 2006a). Those that survive extended anoxia have striking
morphological defects and tissue damage (Scott et al., 2002). There are fewer neurons,
suggesting cell death; there is a pronounced cell-swelling phenotype in the pharynx and
across the body wall muscle, reminiscent of necrosis; there is an axonal beading
phenotype indicating damage to neuronal integrity; nearly all myocytes display nuclear
fragmentation.
Besides temperature and duration of insult, other factors contributing to anoxia
tolerance are developmental stage, diet, genotype and growth conditions (solid agar or
liquid culture). Of the developmental stages, dauer larvae and embryos are the most
tolerant to anoxia (Padilla et al., 2002). Exposure to anoxia for shorter durations (upto 4
hours), also known as anoxic preconditioning, can induce changes in gene expression
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that provide a protective advantage against long term anoxia. This can occur via
changes in the apoptosis pathway (ced-4) (Dasgupta et al., 2007) and induction of the
unfolded protein response pathway (Mao and Crowder, 2010). While subpopulations of
worms can survive long-term anoxia under certain conditions, it does lead to cellular
injury such as loss of tissue integrity, presence of large vaucoles, distortion of the
pharynx and necrotic-like cell swelling (Mendenhall et al., 2006b; Sun et al., 2014).

A note about techniques: Worm biology under anoxic conditions is a relatively young
field of investigation, and it is essential to point out that studies do not have a consistent
method of inducing anoxia. Some studies (including ours) take advantage of
commercially available biobags that generate an anoxic environment in a sealed bag via
catalytic consumption of O2 in the bag. Others use gloveboxes or chambers that are
outfitted to carefully control O2 concentration inside them by replacing it with N2. Some
studies are done on solid agar culture plates and others are done in liquid media. Some
are conducted at standard laboratory 20°C and others are conducted at a range of
different temperatures (25-28°C). Finally, some are conducted in embryos, others at
larval stages of development and yet others in adult worms. As a result of these
variations in different labs for studying anoxia, there are many differences in similar
outcome measures such as percent survival. Some basic observations that have been
repeated by different groups have been consistent across these different techniques, but
there is not enough data to know if every observation is similarly consistent. However, it
is important to remain mindful of these technical differences when evaluating the results
of each study.
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Metabolic regulation of anoxia
Under anoxic stress, worms enter a state of suspended animation and resume
regular physiological activity when re-exposed to normoxic environments. Early studies
of worms in anoxia established that their metabolic rate during anoxia falls to as low as
5% of normoxic levels (Van Voorhies and Ward, 2000). Presumably, this low-activity,
hypometabolic state is an adaptive mechanism to preserve precious energy stores since
reproduction, locomotion and tissue maintenance are energetically costly. Adult worms
will cease all movement and appear ‘stunned’ within 8 hours of anoxia onset
(Mendenhall et al., 2006b). While there are certain mutants (daf-2, the insulin receptor
homolog in worms) that take longer to suspend activity, no studied mutant is capable of
avoiding it completely.
Studies in adult worms show that under anoxia, animals switch their primary
energy source from fat to glycogen/glucose stores. Over a 24h anoxic exposure, animals
can lose up to 2/3rds of their carbohydrate reserve (Föll et al., 1999). In anoxia-tolerant
mutant (daf-2) worms, there is an increase in fat and glycogen production in intestinal
and hypodermal cells (Kimura et al., 1997). Worm homologs of the glycoytic enzyme
glyceraldehyde-3 phosphate dehydrogenase isoforms, gpd-2 and gpd-3, are also
involved in anoxia tolerance (Mendenhall et al., 2006b). RNAi against these genes led to
impaired worms after anoxia. However, these results were confounded because other
glycolytic genes did not similarly induce anoxia sensitivity.
ATP production, as expected, is also markedly reduced during anoxia (Föll et al.,
1999; Padilla et al., 2002). AMP-kinase (AMPK) is the master cellular sensor of the
ATP/AMP ratio. AMPK is generally activated when cellular ATP levels fall, and its activity
leads to an increase in energy producing anabolic processes and a decrease in energy
consuming catabolic processes. Given that ATP levels decline during anoxia, it is
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perhaps to be expected that AMPK activation might be upregulated to allow cells to cope
with this energy deficit appropriately. Worms lacking aak-2, the C. elegans homolog for
the catalytic alpha subunit of AMPK, are in fact hypersensitive to oxygen deprivation
(LaRue and Padilla, 2011). They have decreased survival and those that survive have
defects in motility and/or tissue morphology. Additionally, in one anoxia-tolerant mutant
(daf-2), there is a decrease in stored carbohydrate consumption compared to wild type
worms, and this is partially dependent on AMPK. These data suggest that carbohydrate
availability can impact worm tolerance of anoxia, and AMPK has a role to play in
regulating its consumption.

Mitochondrial changes in anoxia
As the primary site for aerobic ATP synthesis in the cell, it is not surprising that
mitochondria are sensitive to changes in available oxygen. In C. elegans at the L4 stage
of development, 24 hours anoxia induces a stress response wherein neuronal
mitochondria undergo fission, and upon reoxygenation, they refuse and restore their
original shape and size (Ghose et al., 2013). This study shows that, in the suspended
animation state, worms prefer smaller, fewer mitochondria, perhaps as a mechanism for
limiting reactive oxygen species production. Oxidative stress is, however, induced in
anoxia, and successful recovery from anoxia requires activity of the oxidative factor
SKN-1/Nrf to allow proper refusion.
In other studies conducted in adults and in liquid media, mitochondrial damage is
observed after just 12h of extreme oxygen deprivation (<0.2% O2). They have severely
altered morphology, compromised membrane potential as well as accumulation of
protein aggregates (Kaufman and Crowder, 2015). Consistent with protein accumulation,
the authors found that the mitochondrial unfolded protein response (UPRmt), was
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induced in these animals even as early as 4h anoxia, when animals recovered
completely. This indicated that proteostasis in the mitochondria is extremely sensitive to
changes in ambient oxygen. When UPRmt was experimentally induced by doxycycline or
constitutive activation of atfs-1 (the transcription factor required for UPRmt), animals were
protected from anoxic insult as measured by healthier mitochondria, decreased protein
accumulation in the mitochondria and improved survival. Additionally, upregulated UPRmt
was protective both before and after the anoxic insult, suggesting a potential priming
mechanism to protect mitochondria and improve whole animal survival from anoxic
stress.
An independent study from a different group also found that atfs-1 loss of
function mutants were sensitive to 20h anoxia in day 1 adults, and that gain of atfs-1
function was protective as measured by improved survival and decreased axonal
damage (Peña et al., 2016). However, inducing atfs-1 specifically in the nervous system
was able to rescue neurons from damage but was not able to improve survival of the
animal, suggesting either a cell non-autonomous mechanism for atfs-1 or a requirement
of atfs-1 function in different tissues for protection of C. elegans against anoxia.

Cell non-autonomous features of anoxia in C. elegans
Oxygen deprivation is known to cause cell death via cell autonomous and nonautonomous pathways. Cell autonomous mechanisms lead to induction of apopotosis
and necrosis in injured cells (Lipton, 1999). Cell non-autonomous pathways are less well
understood, but lead to injury of secondary cells due to signals released from primary
injured cells. Release of glutamate and potassium from neurons exposed to hypoxia
causes cell death in surrounding neurons (Choi and Rothman, 1990; Broughton et al.,
2009). Another example is that in focal ischemic stroke, there is neuronal death in the
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area of the brain most exposed to the hypoxic insult, but the ischemic penumbra region
surrounding the stroke is initially viable but experiences delayed cell death presumably
due to non cell-autonomous factors from the directly injured neurons (Lo, 2008). As
mentioned above, necrotic-like cell death is observed in worms after an anoxic insult
(young adult worms exposed to 21h of ≤0.3% O2 in liquid culture) (Sun et al., 2014). To
study cell autonomous vs non-autonomous cell death in worms after anoxia, these
authors generated transgenic worm lines that were protected from anoxic death due to a
loss of function mutation in the gene rars-1 (discussed in detail below), with rars-1
rescue in specific cell types – either pharyngeal myocytes or GABA-ergic neurons. In
this manner, just these specific cells were vulnerable to oxygen deprivation while the rest
of the cells in the organism remained protected. They found that these lines had
necrotic-like swelling and damage in cells of the pharynx and the tail, suggesting a cell
non-autonomous mechanism for cellular injury after anoxia. They also found that loss of
function in daf-2, the insulin-like receptor gene in worms, rescued the pharyngeal cellswelling phenotype observed after anoxia, and that this required the C. elegans FOXO
transcription factor homolog daf-16. Interestingly, daf-16 expression in the intestine was
able to rescue survival as well as pharyngeal cell-swelling after extreme oxygen
deprivation, further suggesting a cell-autonomous regulation of anoxia-related injury and
response.
Worms have distinct sets of sensory neurons in their head to detect changes in
ambient oxygen. Upshifts in oxygen are detected by URX, AQR and PQR neurons, while
downshifts in oxygen are detected by the BAG neuron. Indeed, worms deficient in BAG
neurons due to a genetic ablation are unable to sense downshifts in oxygen (Zimmer et
al., 2009). Interestingly, loss of BAG neurons confers a survival advantage in L4-staged
worms exposed to anoxia (Flibotte et al., 2014). These worms, similar to wild type
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animals, enter suspended animation when exposed to anoxia, but have a much higher
rate of survival after 24 hours of normoxic recovery compared to wild type animals.
While 45% of wild type animals survived 48 hours of anoxia, 67% of BAG-deficient
animals survived the same insult (Flibotte et al., 2014). A single neuron is therefore
capable of regulating whole animal survival when exposed to anoxia, providing yet
another example of a cell non-autonomous mechanism for regulating the response to
anoxia.

Gene regulation of anoxia tolerance
In order for cell non-autonomous regulation of anoxic stress to occur, molecular
communication between cells is necessary. Neuropeptides are soluble factors widely
used in C. elegans to communicate between cells and tissues. Our lab recently identified
that loss of function mutations in egl-3 and unc-31 protected developing C. elegans from
anoxia (Flibotte et al., 2014). The egl-3 gene encodes a proprotein convertase required
for the processing and maturation of neuropeptides (Thacker and Rose, 2000; Kass et
al., 2001), and the unc-31 gene encodes the C. elegans homolog of the calciumdependent activator protein for secretion (CAPS), required for the secretion of
neuropeptide-carrying dense core vesicles (Speese et al., 2007). Hence, loss of
neuropeptide signaling is protective against anoxic stress in developing worms.
However, neuropeptide signaling is not necessary in BAG neurons for this protective
phenotype. Restoring egl-3 function specifically in BAG neurons in an egl-3 null
background does not rescue egl-3-mediated increase in anoxic survival (Flibotte et al.,
2014). It remains to be understood which cells neuropeptides might act in for this benefit,
what mechanistic pathways neuropeptides employ to regulate the response to anoxia
and which specific neuropeptides might be involved in extending survival under the
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hypometabolic conditions induced by anoxia. This is the primary focus in chapter 3 of
this dissertation.
Other genes known to affect C. elegans survival against anoxia are enumerated
below. In chapter 3, we explore the contribution of some of these genes to neuropeptidemediated regulation of anoxia survival.
daf-2: Loss of function mutants in daf-2, the worm homolog of the insulin-like growth
factor 1 receptor, leads to strong anoxia resistance in worms. Mutants are able to
survive anoxia (upto 72h) induced in different ways significantly better than wild type
worms (Scott et al., 2002; Mendenhall et al., 2006a). This survival benefit is dependent
on the activation of the transcription factor daf-16, the worm homolog of FOXO,
downstream of daf-2. Further, daf-2 expression in muscle and neurons, but not intestine,
is necessary for this effect. These data implicate the insulin signaling pathway in
regulating worm response to anoxia.
rars-1: Loss of function mutations in rars-1, the worm homolog of the arginyl aminoacyl
t-RNA synthetase (AAR), significantly protects worms from anoxia-induced death
(Anderson et al., 2009). This effect was partially due to induction of the unfolded protein
response. Interestingly, RNAi against almost all other AARs in C. elegans also protected
them from anoxia, suggesting that translational repression plays a critical role in
surviving this stress.
nsy-1: Loss of function mutation in nsy-1, the worm homolog for apoptosis signalregulating kinase (ASK), protects worms against long-term anoxia (Hayakawa et al.,
2011). nsy-1 encodes a MAP kinase kinase kinase (MAP3K), and its activity is required
in many cell types such as hypodermis, neurons and intestine, for this phenotype.
Additionally, a loss of function mutation in MAP2K (sek-1) also improved survival under
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anoxic conditions. Together, these data point to a global role for the MAPK pathway in
regulating anoxia in worms.
hyl-2: Loss of hyl-2, the worm homolog for a ceramide synthase, makes worms
hypersensitive to anoxia (Menuz et al., 2009). In worms, hyl-2 encodes a ceramide
synthase responsible for the de novo synthesis of specific ceramides ranging 20-22
carbon chain lengths. hyl-2 does not depend on apoptosis to induce anoxia sensitivity in
worms, and loss of daf-2 in hyl-2 mutants partially rescues survival of animals
suggesting a potential interaction between these two genes in anoxia survival. Overall,
these data suggest that synthesis of specific ceramides contributes to the worm
response against anoxic insult.
skn-1: Loss of function in skn-1, the worm ortholog for nuclear factor-erythroid-related
factor (Nrf), prevents recovery of worms after anoxic exposure (Ghose et al., 2013).
Compared to wild type worms, skn-1 mutants had significantly impaired recovery of
movement 10 minutes post-anoxia (24h exposure). This lack of behavioral recovery
correlated with increased mitochondrial fission in skn-1 mutant worms, suggesting a role
for skn-1-mediated response to oxidative stress in regulating mitochondrial dynamics
under anoxic stress.

Overall, I will explore the bidirectional role of metabolism in disease and stress by
a) studying how manipulating organismal metabolism can alter progression of a
neurodegenerative disease (ALS) (Chapter 2) and b) studying the contribution of
neuropeptide signaling in a physiological state driven by metabolic adaptation to an
environmental stress (anoxia) (Chapter 3).
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Abstract
Dysfunction and death of motor neurons leads to progressive paralysis in
Amyotrophic lateral sclerosis (ALS). Recent studies have reported organism-level
metabolic dysfunction as a prominent, but poorly understood feature of the disease. ALS
patients are hypermetabolic with increased resting energy expenditure, but if and how
hypermetabolism contributes to disease pathology is unknown. We asked if decreasing
metabolism in the mutant superoxide dismutase 1 (SOD1) mouse model of ALS (G93A
SOD1) would alter motor function and survival. To address this, we generated mice with
the G93A SOD1 mutation that also lacked the melanocortin-4 receptor (MC4R). MC4R is
a critical regulator of energy homeostasis and food intake in the hypothalamus. Loss of
MC4R is known to induce hyperphagia and hypometabolism in mice. In the MC4R null
background, G93A SOD1 mice become markedly hypometabolic, overweight and less
active. Decreased metabolic rate, however, did not reverse any ALS-related disease
phenotypes such as motor dysfunction or decreased lifespan. While hypermetabolism
remains an intriguing target for intervention in ALS patients and disease models, our
data indicate that the melanocortin system is not a good target for manipulation.
Investigating other pathways may reveal optimal targets for addressing metabolic
dysfunction in ALS.
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Introduction
Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease
characterized by loss of upper and lower motor neurons leading to paralysis and death
(Ferraiuolo et al., 2011; Hardiman et al., 2011; Kiernan et al., 2011; Taylor et al., 2016).
Work from a variety of models implicates dysfunctional RNA metabolism, protein
homeostasis, altered mitochondrial function and oxidative stress in disease
pathophysiology (Ferraiuolo et al., 2011; Robberecht and Philips, 2013; Taylor et al.,
2016). In addition to cell-autonomous factors (i.e., the accumulation of toxic misfolded
proteins in motor neurons), there is compelling evidence for non-cell autonomous
processes contributing to disease progression, such as the participation of microglia and
astrocytes (Wang et al., 2010; O'Rourke et al., 2016). At present these insights into ALS
have not translated into drugs that substantively influence the course of disease.
Studies of patients with ALS have provided intriguing evidence for whole
organism metabolic derangements. For example, glucose intolerance is present in 33%
of sporadic ALS patients vs. 9.5% in controls (Pradat et al., 2010), hypermetabolism is
present in 50-60% of ALS patients (Funalot et al., 2009b) and dyslipidemia, measured
by increased LDL/HDL ratio, is present in 45.4% of ALS patients vs 16.1% in controls
(Dupuis et al., 2008). ALS patients have lower body mass index (BMI) and lower lean
body mass compared to healthy controls (Ahmed et al., 2014), and many of these
perturbations present early in disease and are progressive. There is an inverse
correlation between premorbid BMI and risk of ALS; in overweight or obese individuals,
the risk of ALS was reduced 30-40% (O'Reilly et al., 2013). Mouse models of ALS,
based on known familial mutations such as SOD1, TDP43, FUS and C9ORF72, similarly
show energetic abnormalities including mitochondrial dysfunction, decreased body
weight and hypermetabolism (Mattiazzi, 2002; Dupuis et al., 2004; Chiang et al., 2010;
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Stribl et al., 2014; Perera and Turner, 2015). ALS patients fed a high calorie, high
carbohydrate diet showed fewer adverse events, delayed weight loss and longer lifespan
than those fed a control diet (Wills et al., 2014b). Various types of high calorie diets have
been shown to provide benefits to the mutant SOD mouse model of the disease as well
(Dupuis et al., 2004; Zhao et al., 2006; Ari et al., 2014). Together, these
observations provide evidence that organismal metabolism is likely to contribute to the
pathogenesis of ALS.
One approach to investigating the contribution of hypermetabolism (an increase
in resting energy expenditure) to ALS (Bouteloup et al., 2009; Funalot et al., 2009b) is to
genetically decrease metabolic rate in mouse models of disease. For example, placing
the G93A SOD1 mice on a leptin deficient background (G93A;ob+/-) lowers organism
level metabolism (Lim et al., 2014). These mice gain more weight, became
hypometabolic, have improved motor function as well as longer lifespan compared to
G93A SOD1 mice alone. However, this study has several inherent limitations. For
technical reasons, it was not possible to study G93A;ob/ob animals and thus the degree
of hypometabolism achieved was rather modest. In addition beyond its role in energy
homeostasis (by controlling feeding and promoting satiety) leptin has myriad additional
actions, including effects on neuronal development (Ahima et al., 1999; Figlewicz et al.,
2006; Van Doorn et al., 2017). These limitations led us to consider if a different genetic
manipulation that led to a more pronounced hypometabolic phenotype, and obviated the
complexities of leptin deficiency, might lead to a greater improvement in the G93A SOD1
model.
To this end, we crossed G93A SOD1 mice, henceforth referred to as G93A, to
those lacking the melanocortin-4 receptor (MC4R), henceforth referred to as MC4R-/-,
generating double mutant G93A;MC4R-/- mice (see methods and Fig. 2.1a for breeding
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strategy). We chose this gene since MC4R null mice are shown to be hypometabolic and
hyperphagic (Huszar et al., 1997; Ste Marie et al., 2000). Additionally, MC4R is a good
candidate because of its central role in energy homeostasis (Krashes et al., 2016). It is
expressed in the anterior bed nucleus of the stria terminalis, paraventricular nucleus of
the hypothalamus and lateral hypothalamus and regulates food intake, metabolic rate
and body weight. Mice lacking this receptor cannot promote energy expenditure, leading
to hypometabolism, hyperphagia and weight gain. Our goal was to genetically induce
hypometabolism in G93A mice by placing them in the MC4R null background, thus
altering a central component of energy balance, and test the effect of this specific
manipulation on metabolism, disease progression and survival.

Results

G93A mice lacking the melanocortin-4 receptor are obese, hyperphagic and
lethargic

Body weight. Beginning at P40, WT mice (C57Bl/6) of both sexes gained weight over the
subsequent 40 weeks (Fig. 2.1b, c). MC4R-/- mice also gained weight over the same
period, however, they were heavier than WT mice at every recorded time point. For
example, at week 10 of measurements (P110), female and male WT mice weighed an
average of 28.3g and 34.9g respectively, while MC4R-/- mice weighed 58.6g and 57.9g
respectively. G93A mice of both sexes also gained the same amount of weight as WT
mice until about P103 (9-11 weeks after P40), after which they progressively lost weight
until they were moribund. G93A;MC4R-/- mice of both sexes gained the same amount of
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weight as MC4R-/- mice until about P124 (11-12 weeks after P40), after which they
progressively lost weight until they were moribund. At P110, female and male G93A
mice weighed an average of 24.9g and 29.2g respectively, while G93A;MC4R-/- mice
weighed 55g and 53.4g respectively. These results indicate that, as previously reported
(Huszar et al., 1997; Balthasar et al., 2005), MC4R-/- mice gain significantly more weight
compared to WT mice as they age, and G93A mice too gain significant weight when
MC4R function is ablated, in comparison to WT and G93A animals.

Feeding. Next, we used the comprehensive lab animal monitoring system (CLAMS, see
methods) to study food consumption in these mice over a 24h period at P60, P90 and
P120 (Fig. 2.1d, e). When all four genotypes (WT, G93A, MC4R-/-, G93A;MC4R-/-) were
compared, group differences were found by one-way ANOVA for females (P60: F(3,25) =
4.476, p = 0.012; P90: F(3,21) = 5.924, p = 0.0043; P120: F(3,21) = 1.56, p = 0.2287) and
males (P60: F(3,19) = 1.311, p = 0.2998; P90: F(3,22) = 3.579, p = 0.0302; P120: F(3,20) =
1.552, p = 0.232). Female WT mice consumed 3-4g of food over 24h at P60, P90 and
P120, while male WT mice consumed 4-5g of food at the same times. Female and male
MC4R-/- mice, in comparison, consumed more food than WT mice (4-5g and 6-7g
respectively) at these time points but this did not achieve significance in post hoc
analyses. Female and male G93A mice had similar amounts of food consumption
compared to WT mice (3-4g and 4-5g respectively), and female and male G93A;MC4R-/mice had similar amounts of food consumption compared to MC4R-/- mice (5g and 5-6g
respectively). Importantly, female G93A;MC4R-/- mice had significantly greater food
consumption than G93A mice at P60 and P90 (post hoc, p<0.05 at P60 and p<0.01 at
P90), but not at P120. Male G93A;MC4R-/- mice consumed more food than G93A mice
at all age points, but this did not reach statistical significance. These results demonstrate
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that WT and G93A mice have similar daily food consumption, and MC4R-/- and
G93A;MC4R-/- mice have similar daily food consumption that is greater than WT and
G93A mice.

Figure 2.1. Breeding strategy, body weight and food intake in study mice.
(a) Two step breeding strategy for generating study mice. Parentheses indicate the
expected genotype frequencies of the progeny in each cross. The relevant animals used
in this study are represented inside the box in the F2 generation. Body weight
measurements in female (b) and male (c) WT, G93A, MC4R-/- and G93A;MC4R-/- mice,
recorded weekly after P40. The vertical dashed lines represent P60, P90 and P120 when
measurements of food intake, ambulatory activity, metabolic rate and motor function were
made. Food intake measurements over a 24h period at P60, P90 and P120 in female (d)
and male (e) mice. Significance measured by one-way ANOVA among genotypes at each
time point, followed by Tukey’s test for multiple comparisons: p<0.05 (*), p<0.01 (**),
p,0.001 (***), p<0.0001 (****).

Ambulatory activity. We also used the CLAMS to look at ambulatory (non-grooming)
activity of these mice over 24h at P60, P90 and P120 (Fig. 2.2a, b). Three parameters
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were measured at each age: total activity over 24h, activity during the 12h light period
and activity during the 12h dark period. Group differences within the 4 genotypes (WT,
G93A, MC4R-/- and G93A;MC4R-/-) were determined using one-way ANOVA at each
age, followed by post hoc analysis with Tukey’s test for multiple comparisons.
a) Total Activity. Group differences were found in total activity over 24h at P60, P90 and
P120 for females (P60: F(3,26) = 9.546, p=0.0002; P90: F(3,24) = 36.55, p<0.0001; P120:
F(3,23) = 34.36, p<0.0001) and males (P60: F(3,20) = 7.346, p=0.017; P90: F(3,22) = 15.31,
p<0.0001; P120: F(3,21) = 8.289, p=0.0008). MC4R-/- mice of both sexes were significantly
less active than WT mice at all three ages (post hoc, p<0.05). G93A mice of both sexes
were as active as WT mice at all three ages. G93A;MC4R-/- mice of both sexes were as
active as MC4R-/- mice, and were significantly less active compared to G93A mice at all
three ages for females and at P90 and P120 for males (post hoc, females p<0.01, males
p<0.05).
b) Light Period Activity. Group differences were found in activity of the mice during the
12h light period at P60, P90 and P120 in females (P60: F(3,25) = 5.328, p=0.0056; P90:
F(3,22) = 20.76, p<0.0001; P120: F(3,23) = 19.32, p<0.0001) and males (P60: F(3,20) = 7.939,
p=0.0011; P90: F(3,22) = 4.413, p=0.0142; P120: F(3,21) = 19.51, p<0.0001). MC4R-/- mice
of both sexes were significantly less active than WT mice at all three ages for females
and at P60 and P120 for males (post hoc, p<0.05). G93A mice of both sexes had similar
activity compared to WT mice at all three ages. G93A;MC4R-/- mice of both sexes were
as active as MC4R-/- mice, and were significantly less active compared to G93A mice at
P90 and P120 (post hoc, females p<0.001, males p<0.05).
c) Dark Period Activity. Group differences were found in the activity of the mice during
the 12h dark period at P60, P90 and P120 in females (P60: F(3,25) = 9, p=0.0003; P90:
F(3,22) = 28.5, p<0.0001; P120: F(3,23) = 32.57, p<0.0001) and males (P60: F(3,20) = 6.436,
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p=0.0032; P90: F(3,22) = 17.46, p<0.0001; P120: F(3,20) = 6.302, p=0.0035). MC4R-/- mice
of both sexes were significantly less active than WT mice at all three ages (post hoc,
p<0.05). G93A mice of both sexes had similar activity compared to WT mice at all three
ages. G93A;MC4R-/- mice of both sexes were as active as MC4R-/- mice, and were
significantly less active compared to G93A mice at P90 and P120 for females and at P90
for males (post hoc, females p<0.01, males p=0.0001).

Figure 2.2. Ambulation in study mice.
Ambulatory activity measured by beam breaks recorded at P60, P90 and P120 in female (a)
and male (b) mice. Significance measured by one-way ANOVA among genotypes at each
time point, followed by Tukey’s test for multiple comparisons: p<0.05 (*), p<0.01 (**), p,0.001
(***), p<0.0001 (****).

These data indicate that WT and G93A mice have similar activity levels at the
measured time points both in the light and the dark cycles. During the same periods,
MC4R-/- mice are significantly less active than WT mice and G93A;MC4R-/- mice have
similar activity levels as MC4R-/- mice, significantly less than G93A mice alone.

29

In summary, G93A mice begin to lose weight compared to WT mice as they age.
However, their food intake and activity levels are similar to WT mice at all recorded ages
and even as they are losing weight, indicating a hypermetabolic phenotype. In all three
measures - weight gain, food intake and activity level - G93A;MC4R-/- mice are
indistinguishable from MC4R-/- mice. They are overweight, feed more and have greatly
reduced activity compared to G93A mice, indicating that ablation of MC4R leads to
unambiguous and significant phenotypic changes in G93A mice. Manipulating the
activity of MC4R is thus a reasonable way to induce changes at the whole organism
level in this mutant SOD1 background.

G93A mice lacking the melanocortin-4 receptor are hypometabolic

In order to determine metabolic flux in test mice over time, we measured average
total oxygen consumption and carbon dioxide production per hour, per kg over a 24h
period at the three different ages (P60, P90 and P120) using indirect calorimetry by the
CLAMS (Fig. 2.3a, b). We also looked at the O2 consumption and CO2 production during
the 12h light period (Fig. 2.4a, b) and 12h dark period (Fig. 2.5a, b) within the 24h
recording. Group differences between the genotypes (WT, G93A, MC4R-/- and
G93A;MC4R-/-) were determined using one-way ANOVA at each age, followed by post
hoc analysis with Tukey’s test for multiple comparisons.

Total O2 consumption (Fig. 2.3a). Group differences in O2 consumption over 24h were
found at P60, P90 and P120 for females (P60: F(3,25) = 5.259, p=0.0060; P90: F(3,22) =
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13.61, p<0.0001; P120: F(3,24) = 17.07, p<0.0001) and males (P60: F(3,20) = 3.3916,
p=0.0238; P90: F(3,22) = 2.434, p=0.0919; P120: F(3,21) = 9.607, p=0.0003). Female
MC4R-/- mice had significantly less O2 consumption than WT mice at P90 and P120
(post hoc, p<0.05), while male MC4R-/- mice had decreased O2 consumption compared
to WT mice at all three ages but this did not achieve significance. Female G93A mice
had significantly more O2 consumption than WT mice at P90 (post hoc, p<0.05),
whereas male G93A mice had increased O2 consumption compared to WT mice at P60
and P120 but this did not achieve significance. G93A;MC4R-/- mice of both sexes were
similar compared to MC4R-/- mice, and had significantly less O2 consumption compared
to G93A mice at all three ages for females and at P60 and P120 for males (post hoc,
females p<0.01, males p<0.05).

Total CO2 production (Fig. 2.3b). Group differences in CO2 production over 24h were
found at P60, P90 and P120 for females (P60: F(3,25) = 4.258, p=0.0147; P90: F(3,22) =
10.67, p=0.0002; P120: F(3,24) = 15.85, p<0.0001) and males (P60: F(3,20) = 3.852,
p=0.0252; P90: F(3,22) = 1.681, p=0.2002; P120: F(3,21) = 6.699, p=0.0024). Female
MC4R-/- mice had significantly less CO2 production than WT mice at P120 (post hoc,
p<0.05), while male MC4R-/- mice had decreased CO2 production than WT mice at all
three ages but this was not statistically significant. Female G93A mice had significantly
greater CO2 production than WT mice at P90 (post hoc, p<0.05), whereas male G93A
mice had increased CO2 production compared to WT mice at P60 and P90 but this was
not statistically significant. G93A;MC4R-/- mice of both sexes were similar compared to
MC4R-/- mice, but had significantly less CO2 production compared to G93A mice at all
three ages for females and at P60 and P120 for males (post hoc, p<0.05 for females and
males).
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Figure 2.3. Oxygen consumption and carbon dioxide production over one day
(24h) in study mice.
Total O2 consumption (a) and CO2 production (b) in female and male WT, G93A,
-/-/MC4R and G93A;MC4R mice at P60, P90 and P120 measured in mL, per hour,
per kg mass of the animal over 24 hours of recording, including light and dark cycles.
Significance measured by one-way ANOVA among genotypes at each time point,
followed by Tukey’s test for multiple comparisons: p<0.05 (*), p<0.01 (**), p,0.001
(***), p<0.0001 (****).

Light Period O2 consumption (Fig. 2.4a). Group differences in oxygen consumption
during the12h light period were found at P60, P90 and P120 for females (P60: F(3,25) =
3.271, p=0.0378; P90: F(3,22) = 7.161, p=0.0016; P120: F(3,24) = 10.16, p=0.0002) and
males (P60: F(3,20) = 1.16, p=0.3498; P90: F(3,22) = 0.747, p=0.5357; P120: F(3,21) = 5.867,
p=0.0045). Female MC4R-/- mice had significantly less O2 consumption than WT mice at
P120 (post hoc, p<0.05), while males had decreased O2 consumption compared to WT
mice at P60 and P120, but this was not significant. Female G93A mice had significantly
greater O2 consumption than WT mice at P90 (post hoc, p<0.05), whereas male G93A
mice had increased O2 consumption compared to WT mice at P120, but this was not
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significant. G93A;MC4R-/- mice of both sexes were similar compared to MC4R-/- mice,
but had significantly less O2 consumption compared to G93A mice at all three ages for
females and at P120 for males (post hoc, females p<0.05, males p<0.05).

Light Period CO2 production (Fig. 2.4b). Group differences in CO2 production during the
12h light period were found at P60, P90 and P120 for females (P60: F(3,25) = 3.337,
p=0.0354; P90: F(3,22) = 5.136, p=0.0076; P120: F(3,24) = 10.79, p=0.0001) and males
(P60: F(3,20) = 1.326, p=0.2939; P90: F(3,22) = 0.4866, p=0.6951; P120: F(3,21) = 5.126,
p=0.0081). MC4R-/- mice of both sexes had decreased CO2 production than WT mice at
P60 and P120 but this was not statistically significant. G93A mice had increased CO2
production compared to WT mice at P90 and P120 in females and P120 in males but
this was not statistically significant. G93A;MC4R-/- mice of both sexes were similar
compared to MC4R-/- mice, but had significantly less CO2 production compared to G93A
mice at all three ages for females and at P120 for males (post hoc, p<0.05 for females
and males).
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Figure 2.4. Oxygen consumption and carbon dioxide production during the 12h
light cycle in study mice.
Light cycle O2 consumption (a) and CO2 production (b) in female and male WT, G93A,
-/-/MC4R and G93A;MC4R mice at P60, P90 and P120 measured in mL, per hour, per kg
mass of the animal over 12 hours of recording during the light cycle of the day.
Significance measured by one-way ANOVA among genotypes at each time point,
followed by Tukey’s test for multiple comparisons: p<0.05 (*), p<0.01 (**), p,0.001 (***).

Dark Period O2 consumption (Fig. 2.5a). Mice of all genotypes had increased O2
consumption in the dark compared the light period, consistent with their increased
nocturnal activity. Group differences in O2 consumption during the 12h dark period were
found at P60, P90 and P120 for females (P60: F(3,25) = 6.772, p=0.0017; P90: F(3,22) =
29.86, p<0.0001; P120: F(3,24) = 24.78, p<0.0001) and males (P60: F(3,20) = 9.646,
p=0.0004; P90: F(3,22) = 9.709, p=0.0003; P120: F(3,21) = 11.98, p<0.0001). MC4R-/- mice
of both sexes had significantly less O2 consumption than WT mice, at P90 and P120 for
females and at P120 for males (post hoc, females p<0.01, males p<0.05). Female G93A
mice had significantly greater O2 consumption than WT mice at P90 (post hoc, p<0.05),
whereas male G93A mice had increased O2 consumption compared to WT mice at P60
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and P120, but this was not statistically significant. G93A;MC4R-/- mice of both sexes
were similar compared to MC4R-/- mice, and had significantly less O2 consumption
compared to G93A mice at all three ages (post hoc, p<0.01).

Dark Period CO2 production (Fig. 2.5b). Similar to O2 consumption, mice of all genotypes
had increased CO2 production in the dark compared the light period, consistent with their
increased nocturnal activity. Group differences in CO2 production during the 12h dark
period were found at P60, P90 and P120 for females (P60: F(3,25) = 4.646, p=0103; P90:
F(3,22) = 20.56, p<0.0001; P120: F(3,24) = 19.56, p<0.0001) and males (P60: F(3,20) = 8.061,
p=0.0010; P90: F(3,22) = 3.994, p=0.0206; P120: F(3,21) = 6.135, p=0.0037). Female
MC4R-/- mice had significantly less CO2 production than WT mice at P90 and P120 (post
hoc, p<0.05), whereas male MC4R-/- mice had decreased CO2 production compared to
WT mice at all ages but this was not statistically significant. Female G93A mice had
significantly increased CO2 production compared to WT mice at P90 (post hoc, p<0.05),
while male G93A mice had increased CO2 production compared to WT mice at P60 and
P120 but this was not statistically significant. G93A;MC4R-/- mice of both sexes were
similar compared to MC4R-/- mice, but had significantly less CO2 production compared to
G93A mice at all three ages (post hoc, p<0.05 for females and males).
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Figure 2.5. Oxygen consumption and carbon dioxide production during the 12h
dark cycle in study mice.
Dark cycle O2 consumption (a) and CO2 production (b) in female and male WT,
-/-/G93A, MC4R and G93A;MC4R mice at P60, P90 and P120 measured in mL, per
hour, per kg mass of the animal over 12 hours of recording during the dark cycle of
the day. Significance measured by one-way ANOVA among genotypes at each time
point, followed by Tukey’s test for multiple comparisons: p<0.05 (*), p<0.01 (**),
p,0.001 (***), p<0.0001 (****).

Together, these data from indirect calorimetry suggest that compared to WT
animals, G93A mice display a moderately higher metabolic rate and that MC4R-/- mice
are hypometabolic. Interestingly, both the G93A hypermetabolism and the MC4R-/hypometabolism is more striking in females than in males, and when the animals are in
the dark. When G93A mice are placed in the MC4R-/- background, their metabolic profile
is similar to MC4R-/- mice alone, for both males and females. G93A;MC4R-/- mice are
significantly more hypometabolic compared to G93A mice in both dark and light periods.
This suggests that MC4R ablation, in addition to affecting weight, food intake and
activity, can also rescue the hypermetabolic phenotype in this mutant SOD1 model of
ALS.
36

G93A mice lacking the melanocortin-4 receptor do not have improved motor
function

Motor function of G93A mice deteriorates over time (Feeney et al., 2001). We
asked if induction of hypometabolism blunted this age dependent phenotype. To this
end, we measured forelimb and hindlimb grip strength in male and female study mice at
P60, P90 and P120.

Forelimb Strength (Fig. 2.6a). Group differences in forelimb grip strength among
genotypes (WT, MC4R-/-, G93A, G93A;MC4R-/-) were found using one-way ANOVA at
each age point for females (P60: F(3,27) = 1.724, p=0.1856; P90: F(3,29) = 12.77, p<0.0001;
P120: F(3,30) = 50.14, p<0.0001) and males (P60: F(3,24) = 9.174, p=0.0003; P90: F(3,26) =
15.69, p<0.0001; P120: F(3,29) = 66.43, p<0.0001).
MC4R-/- mice of both sexes had similar forelimb grip strength compared to WT
mice at all three ages. G93A mice of both sexes had significantly decreased forelimb
grip strength compared to WT mice, at P90 and P120 for females and at all three ages
for males (post hoc, females p<0.001, males p<0.01). G93A;MC4R-/- mice of both sexes
had significantly decreased forelimb grip strength than MC4R-/- mice at P90 and P120
(post hoc, females p<0.001, males p<0.01), and had similar forelimb grip strength
compared to G93A mice at all three ages. The only exception was that female
G93A;MC4R-/- mice had significantly improved grip strength compared to G93A mice at
P120 (post hoc, p<0.05).
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Hindlimb Strength (Fig. 2.6b). Group differences in hindlimb grip strength among
genotypes (WT, MC4R-/-, G93A, G93A;MC4R-/-) were found using one-way ANOVA at
each age point for females (P60: F(3,27) = 12.66, p<0.0001; P90: F(3,29) = 25.69, p<0.0001;
P120: F(3,30) = 57.73, p<0.0001) and males (P60: F(3,24) = 7.494, p=0.0010; P90: F(3,26) =
26.7, p<0.0001; P120: F(3,29) = 68.35, p<0.0001).
MC4R-/- mice of both sexes had similar hindlimb grip strength compared to WT
mice at all three ages, with one exception: male MC4R-/- mice had significantly increased
hindlimb strength compared to WT mice at P120 (post hoc, p=0.0051). G93A mice of
both sexes had progressively worsening hindlimb grip strength with age, and this was
significantly decreased compared to WT mice at all three ages (post hoc, females
p<0.001, males p<0.05). This difference was larger as the animals aged, at P90 and
P120. G93A;MC4R-/- mice of both sexes had significantly decreased hindlimb grip
strength than MC4R-/- mice all three ages (post hoc, p<0.05). Although female
G93A;MC4R-/- mice had increased hindlimb grip strength compared to G93A mice at all
ages, this did not achieve significance. Male G93A;MC4R-/- mice had similar hindlimb
grip strength compared to G93A mice at all three ages.
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Figure 2.6. Motor function and survival of study mice.
-/Forelimb (a) and hindlimb (b) grip strength of female and male WT, G93A, MC4R and
-/G93A;MC4R mice measured at P60, P90 and P120. Significance measured by oneway ANOVA among genotypes at each time point, followed by Tukey’s test for multiple
comparisons: p<0.05 (*), p<0.01 (**), p,0.001 (***), p<0.0001 (****). Kaplan-Meier
survival plots (c) of female and male study mice. Significance was calculated using the
log-rank (Mantel-Cox) test for survival curve comparison between G93A and
-/G93A;MC4R mice, and was set to p<0.05.

These experiments show that G93A mice have significantly less forelimb and
hindlimb grip strength compared to WT mice, indicating progressively impaired motor
function. Importantly, although G93A;MC4R-/- mice are similar to MC4R-/- mice in their
hypometabolic phenotype, they are significantly worse than MC4R-/- mice in grip
strength. In fact, male G93A;MC4R-/- mice are indistinguishable from G93A mice in grip
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strength. In females, there is significantly improved forelimb strength at P120 in
G93A;MC4R-/- mice compared with G93A mice, and there is a consistent trend in
improved hindlimb strength at all time points. Therefore, MC4R ablation has no effect on
the motor function of male G93A mice and has a modest effect in female G93A mice.

G93A mice lacking the melanocortin-4 receptor do not have extended lifespan

Finally we looked at the lifespan of our mice. WT and MC4R-/- mice had similar
longevity and no animals of these genotypes died within 1 year of birth. In agreement
with published work, we found male and female G93A mice had a severely shortened
lifespan compared to WT mice (Gurney et al., 1994), with a median survival of 169.5
days and 167 days respectively (Fig. 2.6c). There was no significant difference in the
lifespan of G93A;MC4R-/- mice compared to G93A mice. Median survival in these mice
was 162 days and 164.5 days for males and females respectively (Fig. 2.6c). Although
the double mutant G93A;MC4R-/- mice reach the pre-determined euthanasia criteria at
the same time as G93A mice, they continue to have significantly higher body weight than
the G93A mice at end stage (Fig. 2.1b, c). Together, these data suggest that ablation of
melanocortin-4 receptor does not significantly prolong the life span of the G93A mouse.

The leptin-MC4R pathway is altered in mice lacking the melanocortin-4 receptor

In addition to their role in controlling food intake and organismal metabolism,
peptide hormones that impinge upon the MC4R signaling pathway can display beneficial
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neuronal activities. In its canonical role in regulating metabolism, leptin acts on two
populations of neurons in the arcuate nucleus of the hypothalamus: the
proopiomelanocortin (POMC)-producing neurons and the agouti-related peptide (AgRP)producing neurons (Krashes et al., 2016). The POMC derived α-melanocyte stimulating
hormone (α-MSH) is an agonist and AgRP is an antagonist of the MC4R. When calories
are replete, α-MSH activates MC4R to promote satiety, feeding suppression, and weight
loss by energy expenditure. When calories are depleted AgRP antagonizes MC4R to
promote energy consumption and blunt energy expenditure. With regard to beneficial
neuronal activities, α-MSH can promote cognitive recovery in a mouse model of
Alzheimer’s disease (Ma and McLaurin, 2014) and demonstrates general antiinflammatory properties (Caruso et al., 2007; Brzoska et al., 2008). Similarly, higher
circulating leptin is associated with decreased risk of Alzheimer’s disease and protection
against cognitive decline (Holden et al., 2009). Due to their varied actions, we asked if
the expression of serum leptin and α-MSH might be altered in G93A and MC4R-/animals in order to clarify the role of these peptides in our experiments.
We measured plasma concentrations of leptin and α-MSH in adult male WT,
MC4R-/- and G93A mice. α-MSH levels were decreased in both MC4R-/- and G93A mice
compared to WT (Fig. 2.7a), but this did not achieve significance (p = 0.08 for MC4R-/and p = 0.16 for G93A). Leptin levels are moderately decreased in G93A mice (Fig 3.7b)
and markedly increased in MC4R-/- mice compared to WT animals (p < 0.0001),
consistent with the increased body weight and adiposity of these animals (Fig. 2.1). As
seen in previous work (Dupuis et al., 2004; Lim et al., 2014), leptin levels were
decreased in G93A mice compared to WT mice. The modest difference in α-MSH levels
among the genotypes may indicate relatively little contribution of the extra-metabolic
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effects of this hormone on neuronal health. The markedly elevated leptin levels in the
absence of MC4R may indicate a healthful compensatory hormonal response, although if
so, it does not improve motor function or extend life of the G93A mice. In light of the
benefits of haploinsufficiency of leptin demonstrated by Lim et al (Lim et al., 2014), it is
conceivable that increased leptin in the absence of MC4R actually mitigates any
potential benefits of hypometabolism.

Figure 2.7. The leptin-MC4R pathway in G93A SOD1 mice.
-/Plasma α-MSH (a) and leptin (b) concentrations in adult male WT, MC4R mice (n=3 for
each genotype). Significance measured by one-way ANOVA among genotypes,
followed by Tukey’s test for multiple comparisons: p<0.0001 (****). (c) Summary of
alterations in leptin, α-MSH/POMC cells and AgRP/AgRP cells in *G86R SOD1 mice
(Vercruysse et al, 2016) and G93A SOD1 mice. (d) Speculative model of the leptin-/-/MC4R pathway in G93A;MC4R mice based on data from MC4R mice.
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Discussion
An increase in resting energy expenditure, or hypermetabolism, is a distinct
organism-level feature of ALS patients and mouse models (Dupuis et al., 2004; Funalot
et al., 2009a; Dupuis et al., 2011; Tefera and Borges, 2017). Our goal was to generate
an ALS model mouse that was hypometabolic, and test the effect of this manipulation on
key features of disease. In order to induce hypometabolism, we ablated MC4R function
because it is a central regulator of energy metabolism. We successfully generated and
studied mice that are null for MC4R and bear the ALS-linked G93A mutation in the
SOD1 gene. We make two principal observations. First, the G93A;MC4R-/- animals are
markedly hypometabolic as reported by weight gain and indirect calorimetry. Thus the
G93A mutation does not impede the central regulation of metabolism via MC4R.
Second, despite evoking hypometabolism in the G93A animals, the most important
measures of disease (e.g., motor function and longevity) are unaffected. This argues
that genetic blunting of the hypermetabolic phenotype by manipulation of MC4R is an
ineffective intervention for slowing disease progression.

Different mechanisms of inducing hypometabolism in ALS
Prior studies in the G93A mouse model have shown that hypermetabolism does
contribute to disease progression, and we highlight two of them here. In 2004, Dupuis et
al studied male mice in two different ALS-related mutant SOD1 mouse models, G86R
and G93A (Dupuis et al., 2004). They found that in both models, mice had lower body
weight and increased energy expenditure by indirect calorimetry compared to age
matched littermate controls. When the G86R mice were fed a high fat diet consisting of
regular chow supplemented with 21% butterfat and 0.15% cholesterol, they gained
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significantly more weight and had increased fat deposits than those fed regular chow
alone. The high fat diet was associated with slowed motor neuron loss, slowed muscle
denervation and a 20% improvement in mean lifespan. In 2014, Lim et al showed that
the G93A mice were hypermetabolic and decreasing leptin levels (by placing them in a
heterozgous ob+/- background), led to hypometabolism and weight gain in these mice
(Lim et al., 2014). Leptin deficiency also led to improved hindlimb grip strength and led to
a female-specific increase in median lifespan. These studies demonstrate that
ameliorating the hypermetabolic phenotype, either by diet or by a specific genetic
manipulation, can blunt the progression of ALS-like phenotypes in mutant SOD1 models
of ALS.
What does the difference between our current results with MC4R and prior work
by Dupuis et al and Lim et al tell us about the contribution of hypometabolism to ALS?
To address this, it is worth considering leptin and its interaction with MC4R. Leptin is a
circulating hormone that plays a prominent role in controlling food intake and satiety
(Cone, 2005; Krashes et al., 2016). It is released by adipocytes and acts on specific
neurons in the arcuate nucleus of the hypothalamus. These first order neurons then act
on second order neurons in the lateral hypothalamus and the paraventricular nucleus of
the hypothalamus. MC4R is expressed on the second order neurons that receive
opposing inputs based on upstream leptin signaling. When calories are replete, leptinmediated MC4R activation promotes satiety and energy expenditure. When calories are
depleted, circulating leptin is reduced and MC4R is inhibited leading to food
consumption and suppression of energy expenditure. On the surface, the leptin deficient
G93A;ob+/- mice Lim et al studied and the G93A;MC4R-/- mice we studied are similar;
they are both heavier than G93A mice and are hypometabolic. Despite this similarity, it is
surprising that ablating MC4R, leptin’s downstream target, does not confer the same
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benefits on motor function as reduced leptin signaling does. One possibility is that the
beneficial effects of reduced leptin signaling acts via MC4R independent pathways.
Indeed, leptin receptors are expressed in extrahypothalamic neurons in the midbrain and
the cerebellum and in peripheral tissue such as the liver (Cohen et al., 2005; Oldreive et
al., 2008; Davis et al., 2011; Forero-Vivas and Hernández-Cruz, 2014) although the
function of leptin signaling in extrahypothalamic tissues is not well understood. The
reduction in circulating leptin that Lim et al achieved in the ob+/- background may point to
important effects of leptin not captured by MC4R ablation. In light of this, we show here
that mice lacking MC4R have a 20-30 fold increase in circulating leptin and perhaps this
mitigates any potential benefit of hypometabolism induced by loss of MC4R.

The hypothalamic melanocortin pathway in ALS
Recent work indicates intrinsic abnormalities in hypothalamus in ALS. Gorges
and colleagues find significant atrophy of the hypothalamus in sporadic and familial ALS
patients (Gorges et al., 2017). Atrophy presents in presymptomatic stages in familial
mutation carriers and is more severe in patients with lower BMI. This suggests that
changes in the hypothalamus precede changes in metabolism in ALS patients. In a
different study, Vercruysse and colleagues looked specifically at the hypothalamic
melanocortin system in ALS patients and the G86R mutant SOD1 mouse model
(Vercruysse et al., 2016). In the G86R SOD1 mice, there are significantly fewer first
order, MC4R-activating (POMC-expressing) neurons and significantly more first order,
MC4R-inhibiting (AgRP containing) neurons compared to WT mice. These differences
were observed at pre-symptomatic stages and suggest that signaling in the melanocortin
system is downregulated in this ALS model. We too find changes in the MC4R signaling
pathway (e.g., leptin and α-MSH are decreased in G93A mice, Fig. 2.7a and b), although
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we studied the G93A SOD1 model. To test the idea that evoking a hypometabolic state
would be beneficial, Vercruysse et al administered an inhibitor of the melanocortin
system, pioglitazone. This did not lead to weight gain in a clinical trial of ALS patients
and did not lead to increased food intake by the G86R SOD1 mice. Vercruysse et al
attributed the lack of efficacy of pioglitazone to the intrinsic abnormalities in melanocortin
system. On the other hand we show that deletion of MC4R in the G93A mouse can
clearly evoke hypometabolism, regardless of the state of the melanocortin system in
ALS. Vercruysse et al did not study G93A mice, but our data suggest that even if
Vercruysse et al could pharmacologically inhibit melanocortin system and evoke a
hypometabolic state, it may not lead to a meaningful effect on weakness in these
models.
Together, this study, Vercruysse et al (2016), Dupuis et al (2004) and Lim et al
(2014) show that leptin levels are lower in mutant SOD1 mice, there are fewer POMC
neurons, more AgRP neurons and lower trending α-MSH (Fig. 2.7c). Given that loss of
MC4R leads to a large increase in leptin levels, we speculate that contrary to G93A
mice, leptin levels are also upregulated in the G93A;MC4R-/- mice while α-MSH levels
are lowered (Fig. 2.7d). If this is in fact the case, our study also suggests that
upregulating leptin in mutant SOD1 mice may not be beneficial in altering disease
course.

Sex, metabolism and ALS
Differences between males and females may contribute to the effectiveness of
metabolic manipulations in ALS. We find a small but significant female-specific
improvement in forelimb grip strength at P120 in G93A;MC4R-/- mice. In the leptin study,
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Lim et al showed that the increase in median lifespan in G93A;ob+/- mice compared to
G93A mice was female-specific. Dupuis et al only used male mice in their high-fat diet
experiments, but a recent study showed that a diet with low unsaturated fatty acids led to
female-specific decrease in median lifespan and a worsening of disease progression in
G93A mice (Cacabelos et al., 2014). Similarly, metabolic manipulations are shown to
affect male and female animals differently in other ALS studies (Kaneb et al., 2011; Kim
et al., 2012; Eschbach et al., 2013; Lim et al., 2014).
In our study, male MC4R-/- mice have 22% lower O2 consumption and 16% lower
CO2 production at P120 compared to WT mice in the active, dark period. In contrast,
female MC4R-/- mice at the same age and time of day have 37% lower O2 consumption
and 33% lower CO2 production than WT mice. This clearly shows a stronger MC4R
mediated hypometabolic phenotype in females. The results are similar in the G93A
background. Male G93A;MC4R-/- double mutant mice have 18% lower O2 consumption
and 16% lower CO2 production than WT mice at P120 in the dark. In contrast, female
G93A;MC4R-/- mice have 38% lower O2 consumption and 37% lower CO2 production
than WT mice at the same age and phase of day. This indicates that even in the G93A
background, loss of MC4R has a stronger hypometabolic effect in females, which
coincides with improved forelimb strength in females at the same age. Lim et al found
that G93A females had similar circulating leptin as WT mice while G93A males had
decreased circulating leptin compared to WT (Lim et al., 2014). Higher baseline leptin in
female mice may contribute to their differential response to metabolic manipulations in
the Lim et al study and this study. These observations highlight sex-specific
perturbations in metabolism and ALS.
There are well-documented metabolic differences between males and females,
including effects of sex hormones such as estrogen and testosterone (Salehzadeh et al.,
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2011; Mauvais-Jarvis et al., 2013), differences in fat storage (Fried et al., 2015) and food
intake (Hallam et al., 2016), to name a few. As highlighted above with leptin, metabolic
differences are also present between males and females in ALS. In addition, there are
sex-specific differences in ALS presentation and progression. The overall incidence of
ALS is higher in males than in females, and spinal cord onset is more likely in males
while bulbar onset is more likely in females (McCombe and Henderson, 2010). In G93A
mice, females have later onset and longer survival in different genetic backgrounds
(Heiman-Patterson et al., 2005), females have preferentially upregulated
proteasomal activity (Riar et al., 2017) and loss of certain genes like PGC-1α
accelerates disease progression in males but not females (Eschbach et al., 2013). The
complex interaction of metabolic differences with pathophysiology and the differences in
metabolism and disease progression in ALS are just beginning to be studied. It is
therefore important to address male and female subjects differently in any ALS study,
and especially those that perturb metabolism.

The G93A SOD1 mouse model of ALS
Different features of ALS in patients may not be recapitulated in every model of
the disease. Here, we chose the G93A SOD1 mouse since it is the most widely studied
model of ALS. These mice mimic many of the clinical features of the disease in patients,
including hypermetabolism. Unfortunately, there is no systematic study of the level of
hypermetabolism specifically in patients with SOD1 mutations. Hence, it is not known
whether the hypermetabolism in the SOD1 mouse model mimics patient symptoms.
However, a small study showed that patients with familial ALS have a higher incidence
of hypermetabolism than those with sporadic ALS (Funalot et al., 2009a), and SOD1
mutations comprise up to 20% of familial ALS cases. Detailed analysis of the metabolic
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abnormalities in different SOD1 mutations both in patients and in mouse models will help
in designing and interpreting studies of the contribution of metabolism in ALS.
Further, the mutant SOD1 strain we used expresses high levels of the human
G93A SOD1 transgene, leading to a 4-fold increase in SOD1 activity (Gurney et al.,
1994). Compared to other mouse models with different mutations in SOD1, this line has
earlier symptom onset (13-17 weeks) and shorter lifespan (17-26 weeks). In contrast,
the G85R mutant SOD1 mouse model has a later symptom onset (35-43 weeks) and
longer lifespan (37-45 weeks) (Bruijn et al., 1997). It is conceivable that the more
aggressive presentation of ALS-like symptoms in the G93A mouse blunts the potential
therapeutic benefit of hypometabolism. Dupuis et al described a hypermetabolic
phenotype in G93A and G86R mutant SOD1 mice, both of which have earlier onset of
symptoms and short lifespans (Dupuis et al., 2004), but it is unknown if the G85R mice
have a hypermetabolic phenotype. It is thus important to determine the hypermetabolic
phenotype in the G85R SOD1 model, and if it exists, to test the effect of lowering
organismal metabolism in that model.

Molecular mechanisms of hypermetabolism in mutant SOD1-linked ALS
Despite decades of effort, the mechanism by which mutant SOD1 causes motor
neuron death remains unclear. However, accumulating data suggests that soluble, and
not aggregated, misfolded mutant SOD1 could lead to cellular damage by promiscuous
interactions with different molecular pathways, including mitochondrial dysfunction and
reactive oxygen species production (Parone et al., 2013). Damaged mitochondria can
thus affect cellular metabolism, and by extension organismal metabolism. It is plausible
that misfolded, soluble mutant SOD1 in the G93A mice is not affected by ablating MC4R
and is therefore unable to change disease progression in these mice. Indeed, it is not
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known if metabolic changes are caused by disease-linked mutations or if metabolism is
distinct from underlying mutations given the prevalence of aberrant metabolism in
sporadic ALS patients.

Conclusion
While experiments have shown that weight gain, increasing BMI, and decreasing
energy expenditure are associated with lower risk for developing ALS (Paganoni et al.,
2011; O'Reilly et al., 2013; Ngo et al., 2014), not all genetic manipulations for inducing
weight gain and altering metabolism are equal in their effectiveness. The findings
presented here add to the growing understanding of how energetic dysfunction is
coupled to ALS. It is critical to understand the metabolic profile in ALS thoroughly, and to
detail exactly how different dietary and genetic changes influence metabolism in ALS in
a sex-specific way in order to design appropriate therapeutic interventions.

50

Methods
Mouse strains and husbandry
Male hemizygous G93A mutant SOD1 mice (G93A+/-) on the C57BL/6
background (Strain #004435, Jackson Laboratories, Bar Harbor, ME), referred to as
G93A, were crossed with female heterozygous loxTB MC4R mice (MC4R+/-) in the
C57BL/6 background (Balthasar et al., 2005) (Strain #006414, Jackson Laboratories,
Bar Harbor, ME). The G93A mice carry one copy of the human G93A mutant SOD1
transgene, and the MC4R+/- mice contain a transcriptional block cassette before the
MC4R start codon. From the F1 progeny, G93A;MC4R+/- males were crossed with
MC4R+/- females. From the F2 generation, the following groups were used for study
purposes: WT (+/+), G93A, MC4R-/-, G93A;MC4R-/- (Fig. 2.1a). Both males and females
from each group were used for all study parameters. Genotypes were determined by
PCR using tail snip DNA using the following primers – MC4R:
GCAGTACAGCGAGTCTCAGG (wild type forward), CTCCCACAGGCTTATGACACC
(wild type reverse), GTGCAAGTGCAGGTGCCAG (mutant), and SOD1:
CTAGGCCACAGAATTGAAAGATCT (genomic forward),
GTAGGTGGAAATTCTAGCATCATCC (genomic reverse),
CATCAGCCCTAATCCATCTGA (transgene forward), CGCGACTAACAATCAAAGTGA
(transgene reverse).
Mice were housed at 22°C with a 12-hour light dark cycle. They were fed
standard diet (23% protein, 22% fat, 55% carbohydrates). Animals were weighed once a
week at the same time of day starting at P40 for at least 20 weeks. Mice without the
G93A mutation were measured for over 40 weeks. All animal protocols were approved
by the Institutional Animal Care and Use Committee (IACUC) at the Children’s Hospital
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of Philadelphia, and animals were treated in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals.

Study Design
Mice of both sexes with four genotypes (WT, G93A, MC4R-/-, G93A;MCR4-/-)
were studied. The following parameters were measured at P60, P90 and P120: oxygen
consumption, carbon dioxide production, food consumption, ambulatory activity, forelimb
strength and hindlimb strength. P60 is shown to be presymptomatic in G93A mice, while
P90 is symptomatic and P120 is close to end stage (Saxena et al., 2009). We chose
these time points in order to monitor progression of ALS-related and metabolic
phenotypes as animals age. Animals were sacrificed when they were unable to right
themselves within 30 seconds from being supine, and this was recorded as day of death
for survival measurements.

Weight gain, food consumption, activity and metabolic measurements
Food consumption, ambulatory activity and metabolic measurements were made
at the appropriate time points (P60, P90 and P120) using the Comprehensive Laboratory
Animal Monitoring System (CLAMS) (Columbus Instruments, Columbus OH). Animals
were weighed and placed in individual chambers with food and water for 48 hours. Food
consumption was measured in grams by recording the decrease in weight of the premeasured food provided in the chambers. Ambulatory activity was measured in arbitrary
units by the number of infrared beam breaks in the x-y plane of the cage every minute,
thus ruling out grooming-related activity in the z-axis. Oxygen consumption and carbon
dioxide production were measured by indirect calorimetry approximately every 10
minutes and reported in milliliters per hour, normalized by the body weight of the animal
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(mL/hr/kg). Animals were allowed to acclimate to the chambers for the first 24 hours, and
only the data from the final 24 hours was used for analysis.

Motor Output
Grip strength measurements were made at the same time of day at appropriate
time points for the fore and hind paws using a digital grip strength meter (Columbus
Instruments, Columbus, OH). For fore grip measurements, animals were allowed to grip
a bar with their fore paws while being held by their tails, and gently pulled back until they
let go of the bar. The meter recorded the force (in kilogram-force or kgf) with which they
hold on to the bar as they are pulled back. Similarly, hind grip strength was measured as
mice gripped a bar with their hind paws. For each animal, one set of trials comprised 3-5
consecutive trials, and each set was repeated three times, with approximately 3 minutes
between sets for the animal to rest. The average strength for the 12-15 trials was
reported for both the fore and the hind paws at each time point.

Plasma leptin and α -MSH measurements
Mice were anesthetized using carbon dioxide and cardiac extraction was
immediately performed to collect blood from adult WT, G93A and MC4R-/- male mice.
Blood was spun down at 2000g for 20 minutes and supernatant plasma was frozen at 80C until further use. Plasma concentrations of leptin and α-MSH were determined by
the Radioimmunoassay and Biomarkers Core facility at the University of Pennsylvania
using standard ELISA (Leptin: Cat # 22-LEPMS-E01 from ALPCO, Salem NH; α-MSH:
Cat # MBS2516107 from MyBioSource, San Diego CA).
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Statistics
Data were analyzed using Prism (GraphPad Software, La Jolla, CA). Unless
otherwise noted, significant differences within groups were determined using one-way
ANOVA followed by Tukey’s test for multiple comparisons. Survival curves were
analyzed using the log-rank (Mantel-Cox) test for significance. For all tests, the
significance threshold was set to p < 0.05.
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Abstract
Oxygen deprivation, even for short durations, can be extremely injurious to cells.
Neurons are particularly vulnerable to changes in oxygen, and cerebral hypoxia has
debilitating consequences including motor impairments, speech impairments and
memory loss, and can be fatal. The molecular mechanisms underlying extreme oxygen
deprivation are not well understood. Here we describe a novel role for neuropeptide
signaling in regulating survival of the nematode Caenorhabditis elegans under anoxic
conditions. We find that loss of neuropeptide signaling protects worms from extended
anoxia and it does not rely on known pathways in stress tolerance and longevity for this
effect. Loss of genes regulating cellular energy homeostasis and membrane lipid
synthesis suppresses neuropeptide-mediated protection, indicating an important role for
metabolism in surviving extended anoxia. Additionally, the nervous system is necessary
for the secretion of neuropeptides mediating this phenotype, and a screen of
neuropeptide genes identified nlp-40 as a partial regulator of anoxic survival. Together,
these data highlight a potential cell non-autonomous regulation of survival against
extreme environmental stress.
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Introduction
Molecular oxygen is essential to the function and survival of multicellular
organisms. It is the final electron-acceptor of the electron transport chain during
mitochondrial oxidative phosphorylation, and is thus critical for producing the vast
majority of ATP to fuel cellular functions (Rich, 2003). Even short periods of oxygen
deprivation cause cell and organismal damage and death. While all organs are sensitive
to changes in oxygen, the brain is unique in that it consumes the most (20% of total
oxygen consumed) of any organ (Erecińska and Silver, 2001). It is, therefore, also the
most sensitive to oxygen deprivation. There are many injuries and disorders where the
brain experiences decreased oxygen supply, such as sudden cardiac arrest, ischemic
stroke, strangulation, choking, carbon monoxide poisoning and seizures (Hopkins and
Haaland, 2004). Birth-related injuries lead to hypoxic-ischemic encephalopathy in
newborn infants (Volpe, 2001). Depending on the age at injury and the area of brain
affected, there are wide-ranging and severe consequences of oxygen deprivation such
as changes in mood and personality, loss of motor function or speech, memory loss and
cognitive impairment (Yogaratnam et al., 2013). Understanding the genetic and
molecular regulation of cellular response to oxygen deprivation can help design
therapies and drugs to combat its devastating effects.
C. elegans, the soil-living nematode, is a great model to study oxygen
deprivation, and has been used as such across its lifespan (Van Voorhies and Ward,
2000; Padilla et al., 2002; Scott et al., 2002; Peña et al., 2016). It is a relatively simple,
1mm long organism with 959 somatic cells and 302 neurons (www.wormbook.org). It
has a short life cycle (it grows from egg to adult in 3 days and lives for 2-3 weeks), feeds
on bacteria and is transparent, all of which allow for ease of experimental manipulation.
57

Importantly, its neuronal connectivity is completely mapped, its genome shares
significant homology with humans and is completely sequenced, and many molecular
pathways are identical between C. elegans and mammals.
Since it lives in soil, C. elegans generally prefers lower environmental oxygen (512% O2) (Gray et al., 2004). Interestingly, it has distinct responses to moderate and
severe oxygen deprivation (Padilla et al., 2002). Worms can survive, develop and
reproduce under low oxygen, hypoxic conditions (0.5-1% oxygen) while decreasing their
oxygen consumption and locomotion (Jiang et al., 2001). However, under extreme
oxygen deprivation or anoxia (<0.1% oxygen), worms become hypometabolic, and
suspend development, feeding and reproduction (Van Voorhies and Ward, 2000; Padilla
et al., 2002; Nystul et al., 2003). Depending on growth conditions, they can survive in
this ‘suspended animation’ state for long periods (a few days), but eventually die if
oxygen is not reintroduced. Upon reoxygenation, they resume normal activity including
reproduction. While the hypoxic response in C. elegans is extensively studied and
depends on the canonical hypoxia induced factor (hif-1) pathway, the anoxic response is
hif-1-independent and is less well understood (Padilla et al., 2002).
Studies in the past decade have shed light on some features of the worm
response to anoxia. Loss of function in daf-2, the worm homolog of the insulin-like
growth factor 1 (IGF1) receptor, protects worms from anoxia, suggesting a role for
insulin signaling in this response (Scott et al., 2002). This protective effect of daf-2 loss
of function requires activity of its downstream transcription factor daf-16, the worm
homolog of the forkhead box protein O (FOXO). Similarly, loss of function mutation in
nsy-1, a MAP3K, also protects worms from anoxia (Hayakawa et al., 2011). Mutations
the AMPK pathway (LaRue and Padilla, 2011) and the ceramide synthesis pathway
(Menuz et al., 2009) make worms hyper sensitvie to anoxia, suggesting a role for
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metabolism in the worm anoxic response. Indeed, ATP levels decrease during anoxia,
and increase upon re-exposure to air (Van Voorhies and Ward, 2000; Padilla et al.,
2002).
Previous work from our lab shows that the BAG sensory neuron, which detects
downshifts in environmental oxygen, makes worms sensitive to anoxia. In worms where
the BAG neuron is genetically ablated, anoxic survival is significantly higher than wild
type worms (Flibotte et al., 2014). Similarly, we found that in the absence of
neuropeptide synthesis and secretion, worms survive anoxia significantly better (Flibotte
et al., 2014). However, neuropeptide signaling is not required in BAG neurons for this
effect. These experiments utilized a temperature sensitive allele of egl-3 and were
conducted at 25 degrees Celsius to enhance egl-3 loss of function. At this higher
temperature, the temperature sensitive egl-3 mutant continued to be protective against
anoxic insult. Restoring neuropeptide synthesis specifically in BAG neurons in a
neuropeptide synthesis-deficient background did not rescue the survival benefit
conferred by loss of egl-3 mediated neuropeptide signaling. One interpretations of this
result is that there was not sufficient rescue of egl-3 in the BAG neurons. Alternatively,
these data suggest that neuropeptide signaling is not required in BAG neurons, is not
directly related to oxygen sensing, and perhaps works in a parallel, cell non-autonomous
fashion to regulate worm response to anoxia.
How, then, does neuropeptide signaling regulate worm survival against anoxia?
We hypothesize that discrete neuropeptides are secreted by neurons and lead to
inhibition of stress-resistance and longevity pathways to make developing wild type
worms specifically vulnerable to anoxia. To test this hypothesis, we sought to answer the
following questions: Is the regulation of anoxia by neuropeptides specific to this stress?
Which tissues do neuropeptides act in? What known mechanisms in stress resistance
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and longevity, if any, impinge on the regulation by neuropeptides? Which specific
neuropeptides are involved in this anoxic response? How does exposure to anoxic
stress impact worm lifespan? We chose the L4 larval stage of development to address
these questions, since it is known to be sensitive to anoxia (Padilla et al., 2002; Flibotte
et al., 2014), and can approximate hypoxic ischemic encephalopathy experienced at
birth by newborn infants. Our goal is to expand our understanding of the C. elegans
response to anoxia by focusing on the neuropeptide regulation of this stress to address
these questions.
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Results
Loss of neuropeptide signaling protects against anoxic stress in developing C.
elegans
We previously found that loss of function mutations in egl-3 and unc-31 protected
worms against anoxia (Flibotte et al., 2014). EGL-3 is a proprotein convertase required
for maturation of peptide hormones (Thacker and Rose, 2000). It cleaves larger
proprotein peptides into smaller peptides with C-terminal basic residue(s). Loss of egl-3
impedes synthesis of hormones, including neuropeptides. UNC-31 is a calciumdependent activator protein for secretion (CAPS). It is required for fusion and exocytosis
of neuropeptide-containing dense core vesicles at presynaptic membranes (Speese et
al., 2007). Wild-type (N2) survival after anoxia is dependent on the duration of the insult:
80-90% of N2 worms survive 24 hours of anoxia while only 30-50% survive 48 hours of
anoxia (Van Voorhies and Ward, 2000; Padilla et al., 2002; Flibotte et al., 2014). As a
result, we chose 48 hours of anoxic insult to measure changes in susceptibility to this
stress.
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Figure 3.1. Survival of neuropeptide processing and secretion mutants at the L4
stage after 48 hours of anoxia. For a) data were analyzed using one-Way ANOVA
with Tukey’s test for multiple comparisons (n = 4 independent experiments). For b)
data were analyzed using paired t-test (n = 6 independent experiments). *p < 0.05, **p
< 0.01
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We confirmed these findings in egl-3 and unc-31 mutants, and also found that loss of
egl-21 was protective against 48 hours of anoxia (Fig. 3.1a and b). EGL-21 is a
carboxypeptidase that is required for maturation of neuropeptides. It removes the Cterminal basic residue(s) from small peptides generated by EGL-3 (Jacob and Kaplan,
2003). Thus, loss of function of multiple genes required for neuropeptide synthesis and
secretion protect worms from anoxic stress. Interestingly, all three of these genes have
human homologs, and play the same roles in peptide hormone synthesis and secretion
(Thacker and Rose, 2000; Jacob and Kaplan, 2003; Speese et al., 2007).
This protective effect was specific to the L4 stage of development, the final larval
stage before worms enter adulthood. We found that 90-100% of young adult worms
survived 48 hours of anoxia while 30-50% of L4 worms survived the same insult (Fig.
3.2a). The L4 stage of worm development lasts upto 8 hours, during which worms
undergo a variety of physiological changes.
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Figure 3.2. Worms are sensitive to 48 hours of anoxia specifically at the L4 stage. a)
Survival of L4 vs young adult (L4 + 1day) N2 worms after 48 hours of anoxia (n = 4
independent experiments). b) Survival of early L4 vs late L4 worms after 48 hours of
anoxia, using the qIs56 [lag-2::GFP + unc-119(+)] reporter worm to define early and late L4
based on tip cell maturation (n = 5 independent experiments). Data were analyzed using
paired t-test. *p < 0.05

Given that developing worms respond to 48h anoxia differently than mature worms, we
asked if worms in early L4 would be different from those in late L4 in their anoxic
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susceptibility. We used a reporter line qIs56 [(lag-2::GFP) + unc-119(+)] for distal tip cell
maturation (Blelloch et al., 1999) to accurately distinguish early and late L4 worms, and
subjected them to 48h anoxia. There was no significant difference in anoxic survival
between the two sub-stages (Fig. 3.2b).
In addition to O2 depletion, 8-12% CO2 is generated in the biobags used for these
studies (per manufacturer). Work by others suggests that worms reduce pharyngeal
pumping in response to high CO2 levels, and this is in part mediated by egl-21 and unc31 (Sharabi et al., 2014). In order to determine if the worms were responding to
hypercarbia instead of anoxia, we placed L4-staged N2, egl-3 and unc-31 worms in a
chamber with 20% O2 and 10% CO2. After 48 hours in this chamber, none of the lines
had developmentally arrested (‘stunned’) or died as they do in the biobags. Rather, they
had developed to adulthood, laid eggs and these eggs had hatched (data not shown).
We also tested gcy-9 mutant worms, since GCY-9 is known to be necessary for sensing
CO2, thereby regulating worm avoidance to the gas (Hallem et al., 2011). Loss of gcy-9,
however, did not alter survival of worms after 48 hours of anoxia compared to N2
animals (data not shown). Therefore, we concluded that the phenotype we studied was
specific to anoxia.
We also found that protection conferred by loss of neuropeptide signaling was
specific to anoxic stress. Neuropeptide signaling mutants subjected to heat stress, UV
stress or tunicamycin-induced ER stress did not survive any better than N2 worms (Fig.
3.3).
Together, these data show that developing (L4) C.elegans are sensitive to anoxic
stress in a duration-dependent manner, and loss of function mutations in neuropeptide
synthesis and secretion specifically confer a survival benefit against this stress. This
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indicates that neuropeptide signaling makes worms vulnerable to extreme oxygen
deprivation.
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Figure 3.3. Response of neuropeptide signaling mutants to different stresses. a) Survival of embryos after
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Biogenic amines do not underlie unc-31-mediated anoxic survival
In C.elegans, dense-core vesicles are known to package biogenic amines in
addition to peptides (Berendzen et al., 2016). We wondered if unc-31-mediated
protection under anoxia was partially due to loss of biogenic amine signaling. There are
four biogenic amines in C.elegans: serotonin, dopamine, tyramine and octopamine.
These are synthesized by tryptophan hydroxylase (tph-1), tyrosine hydroxylase (cat-2),
tyrosine decarboxylase (tdc-1) and tyramine β-hydroxylase (tbh-1) respectively. In order
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to test their contribution to anoxic survival via UNC-31, we measured survival of worms
with loss of function mutations in each of these enzymes. We found that none of these
mutants had a significant survival benefit compared to N2 (Fig. 3.4), suggesting that loss
of unc-31 confers a survival benefit specifically due to loss of neuropeptide signaling.
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Figure 3.4. Survival of biogenic amine synthesis mutants at L4 after 48 hours of anoxia. N2 and
unc-31 survival was compared against survival of a) tryptophan hydroxylase (tph-1), b) tyrosine
decarboxylase (tdc-1), c) tyramine β-hydroxylase (tbh-1) and d) tyrosine hydroxylase (cat-2). Data were
analyzed using one-way ANOVA with Tukey’s test for multiple comparisons (n = 3 independent
experiments for all).

Neuropeptide synthesis in the nervous system is necessary for survival under
anoxic stress
Reporter studies have shown that UNC-31 and EGL-21 are ubiquitously
expressed in the nervous system and have little detectable expression in other tissues
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(Jacob and Kaplan, 2003; Speese et al., 2007). Similarly, EGL-3 is broadly expressed in
the nervous system, but there is evidence that it is also expressed in non-neuronal cells,
such as the intestine (Hung et al., 2014). We wanted to know which tissue egl-3 loss
was required in for its pro-survival effect under anoxic conditions. To this end, we
generated worms expressing genomic egl-3 under either a pan-neuronal, intestinal or
muscle-specific promoter into the egl-3 mutant background. These lines should be null
for egl-3 in the whole animal except neurons, muscles and intestine, respectively. After
subjecting these lines to anoxia, we found that intestinal and muscle expression of egl-3
did not rescue the survival benefit seen in egl-3 null worms. However, neuronal
expression of egl-3 rescued this survival benefit back to wild-type levels (Fig. 3.5a). We
confirmed this finding using pan-neuronal knockdown of egl-3 using RNAi using a worm
strain sensitized for neuronal RNAi (Firnhaber and Hammarlund, 2013). Compared to
worms raised on empty vector (EV) bacteria, those raised on pan-neuronal RNAi against
egl-3 survived anoxia significantly better (Fig. 3.5b). This indicates that loss of egl-3 in
neurons is necessary to confer survival under anoxia, and that neuropeptides
synthesized in the nervous system make worms susceptible to anoxic stress. These
data are also consistent with the expression pattern of unc-31 and egl-21.
In order to determine which neuronal subpopulations were necessary for the egl3 loss of function phenotype, we similarly conducted RNAi experiments to knock down
egl-3 in glutamatergic, cholinergic, GABAergic and dopaminergic cells specifically. To do
this, we obtained worms that were optimized for dsRNA uptake in the specific neuronal
subtypes (Firnhaber and Hammarlund, 2013). We found that glutamatergic and
GABAergic neurons do mediate this effect, because we saw significantly higher survival
upon egl-3 knockdown in these tissues compared to the same worms fed EV bacteria
after 54h anoxia (Fig 3.5b). In preliminary experiments (n=2) there was no significant
66

difference between EV and egl-3 RNAi groups in cholinergic and dopaminergic neurons
after 72h anoxia. These experiments were done under higher anoxia durations (54h and
72h) since we found that all these lines survived 48h of anoxia very well, making those
data difficult to interpret. Together, these RNAi experiments tell us that loss of egl-3
function in multiple neuronal subtypes, including glutamatergic and GABAergic neurons,
accounts for the survival phenotype of egl-3 null worms.
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Figure 3.5. Neuron-specific regulation of egl-3 mediated survival after anoxia. a) Survival of worm lines
expressing genomic EGL-3 in neurons (PF2B3.3), body wall muscle (Pmyo-3) and intestine (Pges-1) in an egl-3 null
background (n = 3 independent experiments). Data were analyzed using one-way ANOVA with Tukey’s test for
multiple comparisons. b) Survival of lines fed EV (TU3311) or egl-3 RNAi bacteria for at least 2 generations. Each
line expresses either SID-1 or RDE-1 to allow RNAi mediated egl-3 knockdown in neuronal subtypes. Pan-neuronal
= TU3311 (Punc-119::sid-1) (n=6), glutamatergic = XE1582 (Peat-4::rde-1) (n=3), GABAergic = XE1375
(Punc-47::rde-1;Punc-47::mCherry) (n=3), cholinergic = XE1581 (Punc-17::rde-1) (n=2), dopaminergic = XE1474
(Pdat-1::rde-1) (n=2). Data were analyzed using paired t-test between EV and egl-3 RNAi for each line. *p < 0.05,
**p < 0.01

Known stress-resistance/longevity pathways do not regulate neuropeptidemediated survival under anoxia
We wanted to understand the mechanism by which neuropeptide signaling
affects survival under anoxia. Do genes and pathways previously shown to regulate
stress responses also underlie neuropeptide-mediated anoxic susceptibility?
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To test this, we interrogated loss of function mutations in a variety of such genes in the
unc-31 and/or egl-3 background. We tested the following genes due to their described
role in anoxia, hypoxia or general stress resistance/longevity: (i) daf-16 (Scott et al.,
2002; Mendenhall et al., 2006a), (ii) hif-1 (Zhang et al., 2009), (iii) hsf-1 (Hsu et al.,
2003), (iv) skn-1 (Ghose et al., 2013), (v) nsy-1 (Hayakawa et al., 2011). Briefly, we
made double mutants between the mutant gene of interest (i-v above) and unc-31/egl-3
mutants, and subjected them to anoxia. Our reasoning was that if increased anoxic
survival of unc-31/egl-3 mutants was due to the activity of any one of the genes i-v, then
loss of that gene in the unc-31/egl-3 mutant background would reverse the survival
benefit.
We found no significant difference in survival between unc-31 or egl-3 mutant
strains and the respective double mutant strains (Fig. 3.6). Thus, none of these genes
were unable to rescue survival benefit conferred by loss of unc-31 or egl-3. These data
indicate that either these genes act in parallel to neuropeptide signaling, or that
neuropeptide-mediated regulation of anoxia requires the activity of an untested or novel
cellular factor and does not involve most known stress resistance or longevity promoting
pathways.
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Figure 3.6. Survey of canonical stress-resistance and longevity promoting genes in
regulating neuropeptde-mediated anoxia sensitivity. Survival of the following double
mutants containing egl-3 or unc-31 was compared with egl-3 or unc-31 alone. a)
daf-16;unc-31 b) daf-16;egl-3 c) hif-1;unc-31 d) hsf-1;unc-31 e) skn-1;egl-3 f) nsy-1;unc-31.
(n = 3 independent experiments for b), n = 4 for rest). Data were analyzed using one-way
ANOVA with Tukey’s test for multiple comparisons.
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Genes involved in cellular metabolism suppress survival benefit induced by loss
of neuropeptide signaling
Since worms enter a hypometabolic, suspended animation state in order to
survive long term anoxia, we wondered if disrupting genes involved in regulating cellular
metabolism would affect neuropeptide-mediated sensitivity to anoxic stress. AMPassociated kinase (AMPK) is the master cellular sensor of a decrease in the ATP/AMP
ratio. When cellular ATP levels decline, AMPK is activated by phosporylation, and in turn
it promotes anabolic pathways and restricts catabolic pathways in the cell. Studies have
shown that ATP levels decrease during worm anoxia (Van Voorhies and Ward, 2000;
Padilla et al., 2002), and that loss of the worm AMPK, aak-2, also makes worms
vulnerable to anoxia (LaRue and Padilla, 2011). Previous studies have also implicated
the short chain (C20-22) ceramide syntase HYL-2 in regulating C. elegans response to
anoxia (Menuz et al., 2009). Ceramides are essential components of the lipid bilayer,
and are involved in regulating metabolic homeostasis (Bikman and Summers, 2011).
Loss of function mutations in hyl-2 made worms extremely sensitive to anoxia, and lack
of hyl-2 signficantly decreased the survival benefit conferred by mutant daf-2 (Menuz et
al., 2009). We decided to test these two genes to assess their involvement in the
neuropeptide-mediated survival phenotype we observe in developing worms.
First, we confirmed that loss of hyl-2 and aak-2 renders worms hypersensitive to
our anoxic conditions. Next, we studied the genetic doubles hyl-2;unc-31, hyl-2;egl-3,
and aak-2;unc-31. In contrast to other stress-resistance genes discussed in the previous
section, loss of hyl-2 and aak-2 completely suppressed the survival benefit in the egl3/unc-31 mutant background (Figure 3.7a-c and 3.7e). We confirmed the effect of hyl-2
in two different ways: (i) we tested two different loss of function mutations and obtained
the same result (Fig. 3.7a and 3.7b), and (ii) we outcrossed hyl-2 from the unc-31;hyl-2
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double mutant to directly test hyl-2 involvement in survival suppression (Fig. 7d).
Outcrossing hyl-2 reversed the sensitivity to anoxia seen in the double mutant. In fact,
the outcrossed strain had similar survival as the unc-31 mutant alone, confirming that
hyl-2 was necessary for suppression of the unc-31 phenotype. These data indicate that
cellular pathways regulating energy metabolism in the cell are critical to surviving anoxic
stress, and that neuropeptide signaling likely acts downstream of these metabolic factors
in regulating anoxia response.
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Figure 3.7. Anoxia resistance of egl-3 and unc-31 mutants is suppressed by loss of the ceramide
synthase hyl-2 and the ATP/AMP sensor aak-2. All experiments were done with L4 animals under 48 hours
anoxia. a) and b) Survival of two different mutant alleles of hyl-2 in the unc-31 mutant background (n = 8 and 3
independent experiments respectively). c) Survival of mutant hyl-2 in mutant egl-3 background (n=4). d) Survival
of mutant unc-31 after outcrossing hyl-2 from the hyl-2;unc-31 strain tested in (a) (n=4). e) Survival of aak-2
mutant in the unc-31 mutant background (n=3). Data were analyzed using one-way ANOVA with Tukey’s test for
multiple comparisons.

71

The neuropeptide nlp-40 partly regulates C. elegans response to anoxia
Loss of egl-3, egl-21 and unc-31 should lead to an inhibition of all neuropeptide
synthesis in the worm. We predicted that the anoxic survival benefit in these mutant
worms is mediated by either a single neuropeptide or a group of neuropeptides. There is
a rich body of literature that implicates single neuropeptides in regulating complex
behaviors and pathways in worms (Nelson et al., 2013; Cheong et al., 2015; Chen et al.,
2016; Shao et al., 2016; Turek et al., 2016). Therefore, we set out to find putative
neuropeptide(s) that may underlie the effect of egl-3/egl-21/unc-31 loss of function under
anoxic conditions. There are 113 genes encoding over 250 distinct neuropeptides in
C.elegans, most of which do not have clearly defined functions (www.wormbook.org).
These neuropeptide genes are broadly divided into three groups: insulins (ins), FMRFlike peptides (flp) and non-insulin/non-FMRF like peptides (nlp).
The first class of neuropeptides we addressed was the insulins, because (i) loss
of function in the insulin receptor daf-2 is also protective against anoxia and this
protection is dependent on its downstream transcription factor daf-16 (Scott et al., 2002),
and (ii) EGL-3 is known to process ins propeptides to generate their mature, active forms
(Hung et al., 2014). However, the unc-31;daf-16 and egl-3;daf-16 double mutants have
similar survival compared to unc-31 and egl-3 mutants alone (Fig. 3.6a and 3.6b)
suggesting that the unc31/egl-3 effect on anoxia is independent of the DAF-2/DAF-16
pathway. This allowed us to rule out the ins class of neuropeptides, and focus our
search to flp’s and nlp’s. We tested survival of almost all available deletion mutants of
flp’s (29 of 31 total flp’s) and nlp’s (36 of 42 total nlp’s) after 48 hours anoxia (Fig. 3.8a
and 3.8b) in order to find mutants that mimicked the survival benefit seen in unc-31 loss
of function worms.
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For our initial screen, we tested each mutant 2 independent times, with 3
technical replicates each time. We had to reconcile the number of independent
experiments we could carry out here because of the need to balance two competing
issues – getting through the large screen of available mutants, and testing them
thoroughly to avoid the substantial biological variability that is a constant feature of this
anoxia assay. As expected, we did encounter a large amount of biologic variability in
these experiments, making candidate identification challenging. Ultimately, we decided
to narrow down an initial list of mutants that had an average survival greater than 50%
across these 6 observations. The only exception was nlp-15, which was included in the
candidate list because it had very high survival in one of the two experiments. This left
us with 8 flp’s and 9 nlp’s for the secondary screen. One of the strains we tested had a
very large deletion that removed many hundreds of genes (VC30122, which spanned
nlp-25, nlp-26 and nlp-42). Because of this, we had 15 strains encompassing the 17 total
mutations after our initial screen.
To narrow down these candidates further, we employed three different tests – (i)
repeat the experiment for each candidate >3-4 more times, (ii) backcross each line to N2
at least 2X to remove mutations in the background genotype and (iii) rescue the deleted
region in each mutant by injecting a wild-type copy of the gene. We were able to repeat
the experiment in 11 of 14 strains, backcross 11 of 14 strains and rescue 7 of 14 strains.
For most lines, repeating the experiment many times dropped the average survival to
well below 50%, suggesting a high false-positive rate in our initial screen. Additionally,
we noticed that backcrossing the lines led to high variability in the data. One line that
had high survival (flp-3), had to be excluded because backcrossing it reduced its survival
to N2 levels, and fosmid rescue did not reduce its high survival. This indicated that, at
least for this line, background genotype led to a false positive hit in the initial screen.
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Since we did not backcross all the lines before initially testing them, it is possible that by
the same rationale, we may have missed potential hits due to background genetic
contamination. Despite this limited approach, one of the candidates, nlp-40, was able to
pass all three tests of the secondary screen (Fig. 3.8c and 3.8d). However, nlp-40
mutant survival hovers around 50-60% despite backcrossing, suggesting that it is only
partially responsible for the anoxia survival phenotype of unc-31. It is likely that more
than one neuropeptide regulates anoxic survival in C. elegans.
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Figure 3.8. Screen for flp and nlp neuropeptides regulating survival under anoxia. a) Survival of 31 strains
containing deletions of individual flp’s after 48h anoxia (n = 2 independent experiments). b) Survival of 33 strains
comprising 36 deletions of individual nlp’s after 48h anoxia (n=2). Strains highlighted in the orange box in (a) and
(b) were selected as candidates for further screening. c) Survival of candidate flp’s and nlp’s before and after 2X
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PCR fragment containing the genomic locus (n=3-5). Data were analyzed by a two-tailed paired t-test for each
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74

Discussion
C. elegans employs neuropeptides to regulate a wide range of physiological
functions. They are involved in many behaviors such as, among others, locomotion
(Hums et al., 2016), sleep (Nelson et al., 2013), feeding (Cheong et al., 2015), egglaying (Ringstad and Horvitz, 2008), mechanosensation (Hu et al., 2011) and
chemosensation (Cohen et al., 2009). Genes encoding neuropeptides are expressed
widely throughout the nervous system but are also found in non-neuronal tissue such as
intestine, the vulval hypodermis and the gonads. They act both locally at synapses and
over long distances as hormones to coordinate these behaviors within and between
tissues (Rabinowitch et al., 2016).
Here, we establish a novel role for neuropeptides in regulating a specific stress –
extreme oxygen deprivation – in developing C. elegans. We confirm and expand on
previous work (Flibotte et al., 2014) to demonstrate that loss of neuropeptide synthesis
by egl-3 and egl-21, as well as loss of neuropeptide secretion by unc-31, lead to
increased survival when exposed to anoxia. This protective effect of neuropeptide loss is
specific to anoxic stress (Fig. 3.3). Hence, neuropeptide signaling makes worms
vulnerable to anoxic insult in particular. We found that neuropeptide synthesis is
necessary in the nervous system for this effect (Fig.3.5), is independent of insulin
signaling and does not rely on established stress-resistance and longevity-promoting
genes (Fig. 3.6).

Cell autonomous vs cell non-autonomous actions of neuropeptides
The insulin signaling pathway is known to regulate stress-resistance and
longevity in worms, flies and even mammals (Holzenberger et al., 2002; Broughton et
al., 2005; Henis-Korenblit et al., 2010). DAF-2 is the insulin/insulin-like growth factor
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receptor homolog in worms. Insulin-like peptides can bind and activate DAF-2, which
initiates an intracellular phosphorylation signaling cascade ultimately leading to the
sequestration of the transcription factor DAF-16 (worm homolog of FOXO) to the cytosol,
thus preventing transcription of DAF-16 targets. DAF-2 loss of function leads to
increased lifespan and increased tolerance to many stressors including heat, UV
radiation, oxidative stress, hypoxia and anoxia (G J Lithgow, 1995; Murakami and
Johnson, 1996; Honda and Honda, 1999; Scott et al., 2002; Mendenhall et al., 2006b).
We show here that neuropeptide-mediated regulation of survival against anoxia is
independent of the DAF-2/DAF-16 pathway. DAF-2 expression in neurons and muscles,
but not intestines, rescues the extreme hypoxic (<0.3%) survival benefit of daf-2 mutant
worms (Scott et al., 2002). Our data shows that neuropeptide signaling is necessary in
neurons and acts in a parallel pathway to DAF-2/DAF-16, which suggests that the daf-2
mediated survival benefit must be due to its expression in muscles. If the DAF-2/DAF-16
pathway acts in non-neuronal tissues for regulating response to anoxia, it would argue
for two separate, cell autonomous regulatory pathways influencing survival under anoxic
stress. Future studies need to address tissue-specific regulation of anoxia by DAF2/DAF-16.
Neuropeptide-mediated regulation of behaviors can also occur in a cell nonautonomous fashion (Shao et al., 2016). Here, we find that for inducing sensitivity to
anoxia, neuropeptide synthesis is necessary in neurons. The BAG sensory neurons in
worms are responsible for detecting a decrease in environmental oxygen. However,
surviving anoxic stress during development does not require neuropeptide signaling from
BAG neurons (Flibotte et al., 2014), since egl-3 null worms with BAG-specific rescue of
egl-3 continue to survive anoxia similar to egl-3 null worms. The neuropeptide flp-17 is
primarily expressed in BAG neurons (Ringstad and Horvitz, 2008). In this study, we find
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that loss of flp-17 does not protect L4 worms from anoxia (Fig.3.8a), further suggesting
that neuropeptide-mediated regulation of survival under anoxic stress acts in non-BAG
neurons. However, where the neuropeptides act remains to be determined.
We describe nlp-40 as a partial regulator of the worm response to anoxia. The
only published paper about nlp-40 describes its expression to be limited to the intestine
(Wang et al., 2013), which does not agree with our results of neuropeptides in anoxic
regulation. There are two ways to reconcile the differences in our findings: first, it could
be that the nlp-40 mediated regulation of anoxic survival is independent of egl-3 and
unc-31. Perhaps nlp-40 is processed by a proprotein convertase other than egl-3. There
are 5 different proprotein convertases in C. elegans, and their expression and function
remain to be fully understood. Second, it is likely that the reporter construct used in the
study by Sieburth et al did not fully capture nlp-40 expression. Finally, the putative
receptor for nlp-40 is aex-2 (Wang et al., 2013), which is thought to be expressed in
GABAergic neurons, and loss of function mutants of aex-2 are smaller in size and have
a pale appearance similar to nlp-40 mutants. Studying aex-2 mutants under anoxia may
also provide insight into the mechanism of action and cell-type specificity of nlp-40
function. Understanding which cells neuropeptides act on will provide insight into the
mechanism by which peptides induce anoxic sensitivity in worms, and elucidate their
local vs. long range actions for modulating physiological responses.

Metabolism and anoxia
Worms enter a hypometabolic, ‘suspended animation’ state when exposed to
anoxia, wherein they dramatically reduce their metabolic rate (Van Voorhies and Ward,
2000; Padilla et al., 2002). In the absence of oxygen, energy consumption occurs via
breakdown of carbohydrates instead of fats. In fact, carbohydrate stores are depleted by
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two-thirds in adult animals exposed to 24 hours of anoxia (Föll et al., 1999), and worms
mutant for the glycolytic enzyme glyceraldehyde-3 phosphate dehydrogenase (gpd-2
and gpd-3), are sensitive to anoxia (Mendenhall et al., 2006a). ATP/AMP levels are
reduced in embryos exposed to anoxia (Padilla et al., 2002). Consistent with this, worms
mutant for AMPK (aak-2), the master sensor of ATP/AMP, are also sensitive to anoxia,
as shown previously in adult worms (LaRue and Padilla, 2011) and here in L4 worms.
Further, a lipid synthesis promoting transcription factor, SREBP1 is required for fatty acid
accumulation (which requires oxygen) after anoxia (Taghibiglou et al., 2009b).
Ceramides are important components of the lipid bilayer in cells, and HYL-2, a short
chain ceramide synthase, is essential for surviving anoxia (Menuz et al., 2009),
suggesting a role for lipids before anoxia as well. Additionally, diet and nutrition also
contribute to anoxic survival, as worms fed a higher carbohydrate food source survive
long-term anoxia better (LaRue and Padilla, 2011). Mutants for nlp-40 are shown to
deficient in their defacation cycle (Wang et al., 2013) and have a pale appearance,
presumably due to intestinal swelling and altered fat deposits. Together, these
observations suggest an important, but incompletely understood contribution of
metabolism in regulating survival from long-term anoxia exposure.
We find that survival promoted by loss of neuropeptide signaling is completely
suppressed by loss of the ATP/AMP sensor AMPK as well as the short-chain ceramide
synthase HYL-2. AMPK and ceramide synthases are important modulators of cellular
metabolism and cell membrane integrity. What does the lethality of neuropeptide
mutant;aak-2 and neuropeptide mutant;hyl-2 tell us about the role of cellular metabolism
in anoxia? It is interesting to note that hyl-2 loss of function also suppresses the survival
benefit induced by daf-2 in L4 and young adult worms (Menuz et al., 2009; Garcia et al.,
2015). Similarly, loss of aak-2 significantly reduces the survival benefit of daf-2 animals
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(LaRue and Padilla, 2011). Our work here shows that EGL-3/UNC-31 mediated
neuropeptide signaling and DAF-2/DAF-16 mediated insulin signaling are independent
pathways in regulating anoxia survival. AMPK and HYL-2 can thus suppress the effects
of two independent pathways involved in anoxia. These two genes may thus act as
master regulators of energy metabolism in the cell acting upstream of these two
pathways, further implying that cellular energy is critical to surviving anoxia.

Enhancing understanding of neuropeptides and anoxia
While this work reveals a new role for neuropeptide signaling, it also opens up
many potential directions for future study. First, we don’t know why neuropeptide
signaling would make worms sensitive to anoxia. It would be beneficial to understand
how much energy neuropeptide synthesis and secretion requires. Given the important
role of hypometabolism to surviving anoxia, perhaps the cell cannot afford the energy
consumed by neuropeptide signaling. Second, we don’t know when neuropeptide
signaling is necessary for inducing anoxic sensitivity in worms. Is neuropeptide signaling
needed before worms are exposed to anoxia or during the recovery from anoxia? Given
that many N2 worms already appear dead immediately after re-exposure to oxygen, we
would hypothesize that neuropeptide signaling is at least in part necessary before and/or
during exposure to anoxia. The egl-3, egl-21 and unc-31 mutants we use have loss of
function in these genes throughout their life. In order to address this timing issue,
constitutive mutants that lose gene function at different stages of life, and at different
time points before, during and after anoxia will need to be generated. Third, while we
rule out many canonical stress resistance pathways in contributing to anoxia, we do not
know how neuropeptides lead to anoxic sensitivity. One pathway that remains
unexplored in this context is the unfolded protein response (UPR) pathway, which is
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implicated in different stress responses, including anoxia (Kaufman and Crowder, 2015).
Neuropeptide signaling may play a role in regulating the UPR, thus regulating the
response to anoxia.

Conclusion
This work establishes a novel role for neuropeptide signaling in C. elegans
response to extreme oxygen deprivation, thereby expanding on genetic and molecular
regulation of anoxic stress in worms. It suggests that cell non-autonomous regulation
may play a key role of the response to anoxia that is independent of known stress
resistance pathways in worms.
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Methods
Worm husbandry
C. elegans were cultivated at 20 degrees Celsius on nematode growth medium
(NGM) agar surface, unless otherwise stated. NGM plates were seeded with a lawn of
the E. coli strain OP50 as the food source, except in RNAi experiments.

Worm Strains
Strains used in this study are listed in Table 3.1. Double mutants were made
using standard genetic techniques. Mutations were confirmed by PCR genotyping, and
the primers used are also listed in Table 3.1.

Anoxia assay
Worms were synchronized by hypochlorite treatment and eggs were placed on
fresh plates. For each experiment, 30-50 synchronized L4 animals from each genotype
were placed on three fresh plates. Each plate was placed in a separate anerobic biobag
(Becton Dickson, catalog # 261216) along with appropriate co-bagged controls. The
bags were sealed and an anoxic environment (<0.1% O2) was generated by palladium
catalyst mediated consumption of ambient oxygen in the bag (per manufacturer
instructions). A resazurin indicator was included in each bag to confirm oxygen
deprivation. Unless otherwise stated, worms were placed under anoxia for 48h, after
which the bags were opened, and the resazurin indicator confirmed reintroduction of
ambient oxygen in the bag. Anoxia exposure was also confirmed by ‘stunned’ phenotype
of worms once the bags were opened ((Padilla et al., 2002; Flibotte et al., 2014)). Any
bags that failed to achieve anoxia according to the indicator and/or due to the absence
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of ‘stunning’ were excluded from the experiment. Animals were allowed to recover for
24h after anoxia, after which dead and alive animals were manually scored. Animals
were considered alive if they were moving, pumping their pharynx and/or responded to
light touch. Each experiment thus had three technical replicates (3 bags), and
experiments were generally repeated 3-6 times. The average survival fraction across
experiments was reported.

Heat shock assay
Synchronized L4 worms were picked onto fresh plates, sealed with parafilm and
placed in a plastic bag submerged in a 34 degree Celsius water bath. Individual plates
were removed after 5 hours and 12 hours to manually score living/dead animals and
promptly returned to the water bath. Animals were scored alive if they were moving,
pumping their pharynx and/or responded to light touch.

ER stress assay
NGM plates were supplemented with 5mg/mL tunicamycin or equivalent DMSO
vehicle (0.05%) and seeded with OP50 bacteria. Synchronized L4 worms raised on
regular OP50 plates were placed on vehicle or tunicamycin plates and lifespan of worms
on either plate was determined by scoring live/dead animals daily.

UV stress assay
To determine ‘germ cell’ survival, young adult animals were irradiated with 0, 80
and 120 kJ/m2 UV-B and allowed to recover for 24h. Survival of the progeny (eggs laid
for ~3 hrs) of the irradiated adults was then determined by counting dead and alive eggs.
Average results across two independent experiments are presented. In each
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experiment, survival on four replicate plates was determined (the offspring of 16-25
irradiated animals). The xpa-1 mutant, necessary for nucleotide excision repair, was
included as a positive control to demonstrate UV toxicity.
Larval survival was determined by irradiating L1 larvae and scoring the
percentage of animals that arrested/died or survived (developed into L4/adult) 48 hours
later. Average results across two independent experiments are presented. In each
experiment, survival of three replicate plates, each containing between 40 – 160 L1
larvae, was determined. The xpa-1 (ok698) mutant was included as a positive control
(Lans et al., 2010).

Hypercarbia assay
Carbon dioxide was introduced into a sealed chamber fitted with a CO2 controller
(ProCO2 from BioSpherix, Inc) until its concentration was 10% of room air, as measured
by a CO2 sensor in the chamber. A separate sensor measured O2 concentration, which
was 18% of room air. Synchronized L4 worms were placed in this chamber for 48 hours,
after which they were removed and assessed for a ‘stunned’ phenotype and survival.

RNAi experiments
NGM plates were seeded with E. coli expressing empty vector (L4440) or egl-3
RNAi-encoding (C51E3.7) plasmids in order to perform feeding RNAi experiments. We
tested worm strains sensitized to import dsRNA from the bacterial source, and induce
RNAi against the target gene in either all neurons or specific subsets of neurons to
achieve cell-type specific knockdown of egl-3. The strains used were: TU3311 (panneuronal knockdown), XE1581 (cholingergic neuron knockdown), XE1582
(glutamatergic neuron knockdown), XE1375 (GABAergic neuron knockdown) and
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XE1474 (dopaminergic neuron knockdown). Worms from each of these strains were
placed on either empty vector or egl-3 RNAi plates for 3-4 generations to ensure
successful knockdown of egl-3. For anoxia experiments, worms were placed in anerobic
biobags for 54h and allowed to recover for 24h before scoring survival.

Neuropeptide screen
We assembled a list of all nlp’s and flp’s (wormbook.org) and interrogated
Wormbase (wormbase.org) to identify mutants that were putative null. This list of
neuropeptide mutants was obtained from either the CGC or the Japanese Consortium.
We posited that deletion mutants would have the most severe loss of function
phenotype. Any flp or nlp that did not have a deletion mutant available was excluded
from the screen. Using this criterion, we were able to test 29 of 31 total flps (all but flp-23
and flp-32) and 36 of 42 total nlps (all but nlp-4, nlp-6, nlp-13, nlp-16, nlp-33 and nlp-39).
For the initial screen, each strain was tested two independent times, each time with
three bags and with co-bagged N2 and unc-31 worms. The average survival of each
strain across these 6 bags was used to narrow candidates for the secondary screen.
Any stain with >50% average survival was selected for secondary screening. In the
secondary screen, strains were (i) tested in 3 additional independent experiments, (ii)
backcrossed 2x to N2 and retested, and (iii) subjected to rescue experiments using
available fosmid DNA for each mutant (Source Bioscience, Nottingham UK). Fosmids
were injected at 160ng/uL along with pmyo-2::mCherry as a coinjection marker. For nlp40 rescue experiments, the genomic rescue line used (OJ949) was generously donated
by Dr. Derek Sieburth (Wang et al., 2013).

Statistics
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Data were analyzed using Prism (GraphPad Software, La Jolla, CA). Significant
differences between two groups were determined using paired Student’s t-test (twotailed). Significant differences within groups greater than two were determined using
one-way ANOVA followed by Tukey’s test for multiple comparisons. Survival curves
were analyzed using the log-rank (Mantel-Cox) test for significance. For all tests, the
significance threshold was set to p < 0.05.

Table 3.2: A list of worm strains used in this study, along with their genetic
description and primers used for genotyping (where applicable)
Strain
N2
CB928

gene(allele)/genotype
wild-type, Bristol
unc-31(e928)

VC671

egl-3(ok979)

VC461

egl-3(gk238)

KP2018

MT14525
RB864
MT15434

egl-21(n476)
qIs56[(lag-2::GFP) + unc119(+)]
gcy-9(n4470)
xpa-1(ok698)
tph-1(mg280)

MT15620
MT13113

cat-2(n4547)
tdc-1(n3419)

MT9455
RK132

tbh-1(n3247)
egl-3(ok979);PF2B23.3::egl-3

RK133
RK134

egl-3(ok979);Pges-1::egl-3
egl-3(ok979);Pmyo-3::egl-3
uIs60[unc-119p::YFP + unc119p::sid-1]
wpSi11[eat-4p::rde1::SL2::sid-1 + Cbr-unc119(+)]; eri-1(mg366); rde1(ne219); lin15(n744)

JK2868

TU3311
XE1582

PCR primers

Fwd Primer: agtccaactccattcatttgc
Rev Primer (outer): aattccagaactaaggacacg
Rev Primer (inner): atctctacggaagatgcacc
Fwd Primer: ccattggagaaagtggaagc
Rev Primer (outer): aagccagtttgacttttcagc
Rev Primer (inner): ttcccacggaactcgatgc
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XE1375

XE1581

XE1474

wpIs36[unc-47p::mCherry];
wpSi1[unc-47p::rde1::SL2::sid-1 + Cbr-unc119(+)]; eri-1(mg366); rde1(ne219); lin15(n744)
wpSi10[unc-17p::rde1::SL2::sid-1 + Cbr-unc119(+)]; eri-1(mg366); rde1(ne219); lin15(n744)
wpSi6[dat-1p::rde-1::SL2::sid1 + Cbr-unc-119(+)]; eri1(mg366); rde-1(ne219);
lin15(n744)
Fwd Primer: ctctctctgtttctccccgc
Rev Primer (outer): acggacactgttcaactcgt
Rev Primer (inner): gcgagagtagcgatgttgga
Fwd Primer: gaatgccgcatgttccgatc
Rev Primer (outer): cggagcagcaatacaagatg
Rev Primer (inner): atggtgtcttcagtccatacc

GR1307

daf-16(mgDf50)

ZG31

hif-1(ia4)

PS3551

hsf-1(sy441)

FX03411

skn-1(tm3411)/nT1[qIs51]

FX0850

nsy-1(tm850)

FX02031

hyl-2(tm2031)

RB1498

hyl-2(ok979)

RB754

aak-2(ok524)

RK135
RK136

unc-31(e928); daf-16(mgDf50)
egl-3(e928); daf-16(mgDf50)

RK137
RK138

RK140

unc-31(e928); hif-1(ia4)
unc-31(e928); hsf-1 (sy441)
egl-3 (ok979); skn1(tm3411)/nT1
unc-31(e928); nsy-1(tm850)

RK141
RK142

unc-31(e928); hyl-2(tm2031)
unc-31(e928); hyl-2(ok979)

RK143
RK144

egl-3(ok979); hyl-2(tm2031)
unc-31(e928); aak-2(ok524)

NY16

flp-1(yn4)

RK139

Fwd Primer (outer): ctccgaaatctggaacgcc
Fwd Primer (inner): gagattccgaagagaggcg
Rev Primer: caggacgtcaacagcagac
Fwd Primer: gcgattccaggaaatgcacg
Rev Primer (outer): ctccgtatcacactgcttatgg
Rev Primer (inner): tcaacaagtgccacgtcagc
Fwd Primer (outer): cgtactaccatttgtataccg
Fwd Primer (inner): tctcacttctggtctccgg
Rev Primer: cgtcgtcgcaacatctcct
Fwd Primer (outer): cgtactaccatttgtataccg
Fwd Primer (inner): tctcacttctggtctccgg
Rev Primer: cgtcgtcgcaacatctcct
Fwd Primer: cccaatctgccaaatactgac
Rev Primer (outer): cacgaccatacatcaacttcg
Rev Primer (inner): cattgttctgctcatcgagc
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VC2591

flp-2(ok3351)

RK145

flp-2(ok3351)
2X backcrossed

VC2497

flp-3(ok3265)

RK146

flp-3(ok3265)
2X backcrossed

NY226

flp-4(yn35)

RK147

flp-4(yn35)
2X backcrossed

VC20382

flp-5(gk320541)

VC2324
VC20593

flp-6(ok3056)
flp-7(gk951274)

NQ913
PT501

flp-7
flp-8(pk360)

RB2067
RB1989

flp-9(ok2730)
flp-10(ok2624)

FX02706
RB1863

flp-11(tm2706)
flp-12(ok2409)

NQ602

flp-13(tm2427)

VC1957

flp-14(gk1055)

RK148

flp-14(gk1055)
2X backcrossed

VC30176

flp-15(gk960606)

FX04829
MT15933

flp-16(tm4829)
flp-17(n4894)

AX1410
RB1902

flp-18(db99)
flp-19(ok2460)

PT505
RB982

flp-20(pk1596)
flp-21(ok889)

VC3465

flp-22(gk1201)/hT2

VC1971

flp-24(gk3109)

Fwd Primer: gcggattgaatcgttttccg
Rev Primer (outer): ttctcgatgcggaaagttgc
Rev Primer (inner): tttcctcgtccttctcgcc
Fwd Primer: gcggattgaatcgttttccg
Rev Primer (outer): ttctcgatgcggaaagttgc
Rev Primer (inner): tttcctcgtccttctcgcc
Fwd Primer: gccaaatggagcactgtcg
Rev Primer (outer): tttggtagcgtcgggtagg
Rev Primer (inner): aatgagatttggaaagctgc
Fwd Primer: gccaaatggagcactgtcg
Rev Primer (outer): tttggtagcgtcgggtagg
Rev Primer (inner): aatgagatttggaaagctgc
Fwd Primer: cacatgccagtctgcctaca
Rev Primer (outer): ttgttcggtcaagactcggc
Rev Primer (inner): ttgagacagagacgtgacgc
Fwd Primer: cacatgccagtctgcctaca
Rev Primer (outer): ttgttcggtcaagactcggc
Rev Primer (inner): ttgagacagagacgtgacgc

Fwd Primer: aggaaaaccggcaagcctag
Rev Primer (outer): cggcgccataataacatctgc
Rev Primer (inner): cgcccctgtttcctacttct
Fwd Primer: aggaaaaccggcaagcctag
Rev Primer (outer): cggcgccataataacatctgc
Rev Primer (inner): cgcccctgtttcctacttct

Fwd Primer (outer): ctaagcaggcatactacagg
Fwd Primer (inner): aaccacgcaaaatattattcg
Rev Primer: ttggcatgccgaaaaaaggg
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RK149

flp-24(gk3109)
2X backcrossed

VC1982

flp-25(gk1016)

RK150

flp-25(gk1016)
2X backcrossed

VC3017

flp-26(gk3015)

RK151

flp-26(gk3015)
2X backcrossed

VC2012

flp-27(gk3331)

VC2502
VC2423

flp-28(gk1075)
flp-33(gk1038)

RB2269
RB1340

flp-34(ok3071)
nlp-1(ok1469)

RB1341
FX01908

nlp-1(ok1470)
nlp-2(tm1908)

FX03023
RB1609

nlp-3(tm3023)
nlp-5(ok1981)

FX02984
VC1309

nlp-7(tm2984)
nlp-8(ok1799)

FX03572
FX06232

nlp-9(tm3572)
nlp-10(tm6232)

VC40940

nlp-11(gk891596)

RB607

nlp-12(ok335)

RK152

nlp-12(ok335)
2X backcrossed

VC1108

nlp-14(ok1517)

VC1063

nlp-15(ok1512)

RK153

nlp-15(ok1512)
2X backcrossed

VC30240

nlp-17(gk960682)

RB1372
VC40619

nlp-18(ok1557)
nlp-19(gk951891)

Fwd Primer (outer): ctaagcaggcatactacagg
Fwd Primer (inner): aaccacgcaaaatattattcg
Rev Primer: ttggcatgccgaaaaaaggg
Fwd Primer: tttgacccaattcacttgacg
Rev Primer (outer): cttgattggacattgcgcga
Rev Primer (inner): gcactccttttttgcttcgg
Fwd Primer: tttgacccaattcacttgacg
Rev Primer (outer): cttgattggacattgcgcga
Rev Primer (inner): gcactccttttttgcttcgg
Fwd Primer (outer): ggtttgtcatgatcggttgg
Fwd Primer (inner): tcaagtttccctaatccccc
Rev Primer: ttgaagtcttcattagctccg
Fwd Primer (outer): ggtttgtcatgatcggttgg
Fwd Primer (inner): tcaagtttccctaatccccc
Rev Primer: ttgaagtcttcattagctccg

Fwd Primer: tttttgcaacacagtcgccg
Rev Primer (outer): tgatgttcagtacggtctgc
Rev Primer (inner): tcgattggtggtttggatgg
Fwd Primer: tttttgcaacacagtcgccg
Rev Primer (outer): tgatgttcagtacggtctgc
Rev Primer (inner): tcgattggtggtttggatgg
Fwd Primer: tttatgccgtgtcttatgtcc
Rev Primer (outer): gccaggctgtcctattacg
Rev Primer (inner): tcgtttgacgcacttcttcg
Fwd Primer: tttatgccgtgtcttatgtcc
Rev Primer (outer): gccaggctgtcctattacg
Rev Primer (inner): tcgtttgacgcacttcttcg
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RB1396
FX02569

nlp-20(ok1591)
nlp-21(tm2569)

FX06351
FX05531

nlp-22(tm6351)
nlp-23(tm5531)

FX02105

FX01931
VC40420

nlp-24(tm2105)
nlp-25; nlp-26; nlp42(gk963304)
nlp-27; nlp-28; nlp-29; nlp-30;
nlp-31; nlp-34(gk963785)
nlp-29(tm1931)
nlp-32(gk628779)

FX05434

nlp-35(tm5434)

FX05156

nlp-36(tm5156)

RK154

nlp-36(tm5156)
2X backcrossed

LSC59
FX04393

nlp-37(tm4393); IstEx24
nlp-37(tm4393)

FX04780
VC2357

nlp-37(tm4780)
nlp-38(ok2330)

FX04085

nlp-40(tm4085)

RK155

nlp-40(tm4085)
2X backcrossed

VC30122
VC40271

VC20740
RK156
RK157
RK158
RK159
RK160
RK161

Fwd Primer: tgagagacccaccagattgc
Rev Primer (outer): gggaccaagcttcatgtcga
Rev Primer (inner): tgttgcttcaagtcgacgga
Fwd Primer: tgagagacccaccagattgc
Rev Primer (outer): gggaccaagcttcatgtcga
Rev Primer (inner): tgttgcttcaagtcgacgga

Fwd Primer: caagtcgccacatatcccg
Rev Primer (outer): ccacgcgaccattctcttc
Rev Primer (inner): gccgctgaaagttgtgttgt
Fwd Primer: caagtcgccacatatcccg
Rev Primer (outer): ccacgcgaccattctcttc
Rev Primer (inner): gccgctgaaagttgtgttgt

nlp-41(gk963053)
flp-2(ok3351);
WRM061B_H10;
pmyo2::mCherry
flp-3(ok3265);
WRM061B_H10;
pmyo2::mCherry
flp-24(gk3109);
WRM0636B_B10;
pmyo2::mCherry
flp-25(gk1016);
WRM0627A_A09;
pmyo2::mCherry
flp-26(gk3015);
WRM0634D_E12;
pmyo2::mCherry
nlp-15(ok1512);
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OJ949

WRM066C_H12;
pmyo2::mCherry
nlp-40(tm4085); vjEx330[Pttx3::RFP, nlp-40 genomic
DNA(~8.8kb)]
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CHAPTER 4
General Discussion

This body of work highlights the important role of metabolism in two different
scenarios: (i) in Chapter 2, I use a mouse model to study the contribution of a change in
metabolism at the organism-level to ALS progression and (ii) in Chapter 3, I use C.
elegans to study how neuropeptides may contribute to surviving an environmental stress
(severe oxygen deprivation) during which worms enter a hypometabolic state. Each of
these projects generated some key insights into disease and stress and raised
interesting questions for further investigation, some of which I highlight below.

Bridging cellular energy homeostasis and organism-wide metabolic defects in
ALS
The findings presented here focus on organism wide metabolic perturbations in
ALS. However, a key feature of all neurodegenerative diseases is the presence of
mitochondrial dysfunction in the brain and spinal cord (Lin and Beal, 2006). It remains to
be understood how nervous system mitochondrial dysfunction at the cellular level and
organism level metabolic abnormalities are related. Does energy imbalance at the
cellular level, caused by dysfunctional mitochondria, contribute to organism level
changes in weight and glucose homeostasis? Alternatively, is organism level metabolic
dysfunction uncoupled from neuronal mitochondrial damage, and can it be targeted
independently to alter the course of disease progression?
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In familial ALS, as well as the G93A SOD1 mouse model used in the studies
here, mutations in ubiquitously expressed genes such as C9orf72 and SOD1 lead to
specific degeneration of motor neurons. It is not known why motor neurons are
selectively vulnerable to damage. Mitochondrial damage is observed in neurons but also
in non-neuronal tissues, such as liver and skeletal muscle (Nakano and Hirayama, 1987;
Siklós et al., 1996; Sasaki and Iwata, 2007). There are two potential mechanisms by
which cellular mitochondrial dysfunction and organism-wide hypermetabolism in ALS
might be related. (i) Mutant SOD1 leads to peripheral tissue metabolic dysfunction,
which, in aggregate, results in organism-wide metabolic phenotypes. (ii) The nervous
system undergoes pathologic changes due to mutant SOD1, and through cell nonautonomous processes such as hormone signaling, leads to altered metabolism in
peripheral tissue. In either scenario, the trigger is cellular-level abnormality due to
mutant SOD1, which causes a cascade of events in both cell autonomous and nonautonomous ways. The overall, compounded effect of these abnormalities is whole body
metabolic derangement. In addition to changes in ATP production, features of
dysfunctional mitochondria in neurodegenerative diseases include generation of reactive
oxygen species and alterations in the redox status of cells (Lin and Beal, 2006). It is
possible that aberrant mitochondria influence cellular metabolism through any of these
different ways. Regardless, these make mitochondrial dysfunction an attractive
candidate for this trigger.
Figuring out the mechanistic link between mitochondrial defects at the cellular
level and organism-wide hypermetabolic profile in ALS will be a key development in
understanding disease progression.
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Targeting peripheral tissue for hypometabolism
In these studies, MC4R was knocked out in the hypothalamus to induce
hypometabolism in the G93A SOD1 background. Loss of MC4R, in addition to
hypometabolism, also induces hyperphagia and increased fat deposits in these mice
(Balthasar et al., 2005). The increased fat deposition makes mice lethargic and
sedentary, and complicates interpretation of motor function in the ALS context. We were
unable to dissociate its effects on feeding from its effects on metabolic rate. Our goal
was to first generate mice that lacked MC4R globally in the G93A SOD1 background
(G93A;MC4R-/- ), and then cross them to a Sim1-Cre mouse line to re-express MC4R in
the paraventricular hypothalamus. As reported in work by Balthasar et al, this partial
restoration of MC4R was able to reduce obesity in MC4R-/- mice by 60%, while
maintaining their hypometabolic phenotype (Balthasar et al., 2005). We attempted to
make this triple mutant cross in our mice, but did not achieve large enough brood sizes
in both sexes to do the entire range of our experiments. Therefore, we studied the
double mutant mouse containing a global knockout of MC4R in the G93A SOD1
background. Our grip strength data suggest that MC4R mutant animals, while obese and
sedentary, can exert similar if not higher muscle force when compared to WT mice.
Physiologically, however, it is difficult to tease apart these dual actions of MC4R, and
practically, drugs targeting MC4R for obesity have met limited success due to a lack of in
vivo efficacy, side effects and blood brain barrier penetrance (Fani et al., 2014).
It may, therefore, be beneficial to target peripheral sources of metabolic rate
control. One interesting candidate for modulating disease is the gut microbiota, which
harbor as many as 100 trillion diverse bacteria (Ley et al., 2006). Recently, the
relationship between the microbiome and the CNS has begun to emerge (Sharon et al.,
2016). For example, mice lacking the gut microbiome (termed germ-free mice) have
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impaired spatial and object recognition, altered expression of critical neuronal molecules
such as subunits of the dopamine receptor, as well as the brain derived neurotrophic
factor (Bercik et al., 2011; Heijtz et al., 2011; Möhle et al., 2016). They also show
impairments in the blood brain barrier (Braniste et al., 2014). The role of the gut
microbiota is much less understood in the context of neurodegenerative diseases. One
study showed that the G93A SOD1 mouse has a presymptomatic increase in intestinal
permeability and an altered gut microbiome compared to wild type mice (Wu et al.,
2015). The same group did a follow up study and showed that administration of 2%
butyrate, a by product of bacterial fermentation in the gut, reduced intestinal ‘leakiness’,
decreased mutant SOD1 aggregation and increased lifespan by an average of 38 days
in the G93A SOD1 mouse (Zhang et al., 2017). However, there is no report of how the
altered microbiome of G93A SOD1 mice might alter whole body metabolism. It might be
worthwhile to do fecal transplantation studies in these mice, where healthy microbiota
are transplanted into the ALS-like mice, and study changes in metabolism and disease
progression.
In PD, there is a study of fecal transplantation that demonstrated the role the
microbiome might play in motor dysfunction (Sampson et al., 2016). PD patients have an
altered gut microbiome compared to healthy controls (Scheperjans et al., 2015).
Sampson and colleagues showed that the presence of the microbiome led to
manifestation of motor deficits as well as microglial activation in the caudate/putamen of
mice overexpressing α-synuclein. This was dependent on short chain fatty acids
produced by the gut bacteria. Antibiotic administration diminished the microbiome and
led to improved motor pathology. Strikingly, compared to control mice transplanted with
fecal microbiomes from healthy human donors, those transplanted with fecal
microbiomes from PD patients developed significantly altered gut microbiomes of their
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own. They also developed motor dysfunction compared to the control mice. Together,
these studies demonstrate the important role of the microbiome in altering disease
progression, and may act as a peripheral target to manipulate organismal metabolism as
well.

Neuropeptide signaling and metabolism in C. elegans anoxia
Worms have the remarkable ability to survive near-complete oxygen deprivation.
A hallmark of this phenotype is that worms enter a state of suspended animation where
they cease most physiological functions including feeding, developing, reproducing and
locomotion for the duration of the anoxic stress. In this state, they deplete a large
amount of their carbohydrate reserves and decrease ATP production, indicating a
hypometabolic phenotype. Our data also shows that aak-2 (AMPK) mutants are
hypersensitive to this insult, demonstrating a vital role for AMPK in regulating and
directing appropriate energy consumption to survive the stress. The absence of AMPK
continued to be fatal to worms in anoxia even in unc-31 mutant worms, which normally
are anoxia resistant. Work by others shows that loss of AMPK has a similar effect in the
absence of daf-2, which too is anoxia resistant (Mendenhall et al., 2006a). This indicates
that functional AMPK is essential to worm survival in anoxia, and acts as a ‘bottleneck’,
effectively masking the contribution of other pathways such as neuropeptide and insulin
signaling. Similarly, we confirm here that hyl-2 (ceramide synthase) mutants are
hypersensitive to anoxia and that this effect too masks that of anoxia tolerance in both
egl-3 and unc-31 mutants. Ceramides are a class of lipid molecules that are essential for
proper maintenance of cell membranes. Here, too, hyl-2 loss was detrimental to worm
survival even in the daf-2 mutant background (Menuz et al., 2009), suggesting a broad
suppression of anoxia tolerance-promoting pathways.
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There is additional data suggesting a critical role for metabolic
enzymes/transcription factors in anoxia tolerance. A key transcription factor essential for
glucose metabolism and lipid/fatty acid synthesis is SREBP1. Levels of SBP-1, the worm
homolog for SREBP1 (sterol regulatory element binding protein), increase with
increasing duration of anoxia in developing (L3) worms (Taghibiglou et al., 2009b).
Although the authors used different tools to generate anoxia than us, they found that 5
hours of anoxia induced lipid accumulation and increased body size in these worms,
both of which were reversed by knocking down sbp-1. Further, loss of gpd-2 and gpd-3,
worm homologs of isoforms of the glycolytic enzyme glyceraldehyde-3 phosphate
dehydrogenase, led to impairments in worm behavior after anoxia, and they act
downstream of the daf-2/daf-16 pathway (Mendenhall et al., 2006a). Otherwise
protected daf-2 mutants lost their survival benefit when gpd-2 was also mutated.
How are all these genes, essential for various aspects of cellular metabolism,
coordinating their activity under anoxia? Ceramides negatively regulate transcription of
SREBP1 in mammalian cells (Worgall et al., 2002). If this is also true in worms, it might
provide a potential explanation for the mechanism of hyl-2 mutant sensitivity to anoxia.
Perhaps, in the absence of hyl-2, there is an increase in SREBP1 expression and an
increase in lipid accumulation that is toxic to worms. Further experiments are needed to
explore these possibilities and clearly define these relationships with regard to their
regulation of anoxic stress.
Understanding how oxygen deprivation alters metabolism and induces metabolic
changes has important consequences for human health. In an elegant study, it was
demonstrated that SREBP1 inhibition is protective in an in vitro model of focal ischemia
(Taghibiglou et al., 2009a). C. elegans is an excellent tool to study genetic and
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molecular interactions and is ideally suited to study these metabolic gene interactions in
the context of oxygen deprivation.

Multifactorial response to anoxia in worms
Many genes and pathways are implicated in regulating the response to anoxic
stress in worms, such as daf-2 (insulin signaling), nsy-1 (MAP kinase signaling), rars-1
(protein translation), skn-1 (oxidative stress response) and hyl-2 (ceramide synthesis).
To add to this growing list are genes described here – egl-3, unc-31 and egl-21
(neuropeptide signaling). We tested many of the above genes to see if neuropeptide
signaling was dependent on their function for its effects in anoxia. We were unable to
find any interaction, suggesting that most of these pathways acted in parallel to the
neuropeptide signaling pathway. Hence, multiple pathways can potentially regulate the
response to this stress in worms.
Previous work also suggests that there may be more than one mechanism by
which neuropeptide signaling mediates survival in anoxia. Anderson and colleagues
(Anderson et al., 2009) identified that suppressing protein translation (rars-1 loss of
function) makes worms resistant to extreme oxygen deprivation. This was mediated in
part by induction of the unfolded protein response pathway, suggesting that other
mechanisms are also recruited by protein translation to regulate survival after anoxia.
Similarly, there may be small changes in multiple pathways as a result of disrupted
neuropeptide signaling, which in sum lead to improved survival in anoxia.
This idea is also bolstered by the fact that we were unable to find a strong effect
of a single neuropeptide in regulating anoxia susceptibility. Based on results from our
screen, our best candidate is nlp-40, however loss of nlp-40 only provides a partial
increase in survival compared to N2 worms. This suggests the involvement of additional
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neuropeptides in egl-3 mediated anoxia tolerance. Further, our RNAi experiments show
that knocking down egl-3 in multiple neuronal subtypes continues to protect worms from
anoxia, suggesting that many neuronal subtypes may be involved in this regulation.
Overall, our data are consistent with the idea that multiple neuropeptides are released
from multiple neuron-types to make worms sensitive to anoxia. Perhaps small
downstream effects of these neuropeptides summate and make worms broadly
vulnerable to anoxic insult. It may be essential to knock down/out egl-3 in many neurons
to induce an appreciable survival benefit.

Timing of neuropeptide signaling in anoxia
An important question that was not addressed in this dissertation is when
inhibiting neuropeptide signaling is most protective to worms. In other words, when does
neuropeptide activity make wild type worms sensitive to anoxia? We use genetic
knockouts or RNAi to diminish neuropeptide signaling via egl-3, unc-31 and egl-21, so
these worms lack neuropeptide activity throughout their life. Is neuropeptide signaling
requires before, during or after the anoxic exposure (or some combination of these) to
sensitize worms to the stress? In future experiments, conditional knockouts or RNAi
experiments could help to answer this question. Having this information may give us
clues about the role of neuropeptides in modulating this phenotype, and more
appropriately target therapeutic interventions if this were to be translational.
Another important observation in our work, which confirms observations by
others, is that there is a developmental regulation of worm susceptibility to anoxia (Van
Voorhies and Ward, 2000; Padilla et al., 2002). In our assay, L4 staged developing
worms were sensitive to 48h of anoxia, while young adults were resistant. The major
physiological events between these two stages of worm development are vulval
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development, a period of lethargus and the final molt/cuticle development (Raizen et al.,
2008; Schindler et al., 2014; Mok et al., 2015). Studying mutants in these pathways may
clarify if disruption of these events contributes to the sensitivity of worms to anoxia
during L4.

Protein translation, neuropepitde synthesis and anoxia
As mentioned earlier, Anderson et al showed that mutating aminoacyl-tRNA
synthetases had a strong positive effect on worm survival in anoxia (Anderson et al.,
2009). This suggests that decreasing protein translation is beneficial in worms. From an
energetic perspective, observation is consistent with preserving ATP loads during anoxia
and redirecting cell biology away from energy-expensive catabolic processes like protein
translation (one of the primary roles of AMPK). In their study, the authors found that the
effect of reducing protein translation was protective partially due to upregulation of the
unfolded protein response (UPR) machinery.
One idea that we did not explore in our work, is if there is decreased
neuropeptide translation and decreased neuropeptide signaling in the aminoacyl-tRNA
synthetase mutants such as rars-1. In other words, if we tested double mutants bearing
a loss of function in egl-3/unc-31 as well as rars-1, would there be an additive survival
benefit in anoxia, or would the double mutant be similar to either individual mutant? If
there is no additive effect of the two mutations, they likely occur in the same genetic
pathway, suggesting that a rars-1 mutation may act to increase anoxia survival by
decreasing neuropeptide signaling.
Additionally, is the UPR induced in neuropeptide signaling-deficient worms? We
show that egl-3 and unc-31 mutant worms are sensitive to tunicamycin (a UPR inducer)
and have reduced lifespan when raised on tunicamycin. This is a preliminary indicator
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that neuropeptide mutant worms are not resistant to sustained tunicamycin-induced
toxicity, but it is not known if the UPR is induced in unc-31 and egl-3 mutant worms at
baseline or after anoxia. If neuropeptide signaling does not rely on the UPR for its effects
on anoxia, it may help to partially explain the protection conferred by rars-1 deletion.

Data variability
On a technical note, one of the major challenges in the anoxia experiments was
the significant amount of biological variability in the data. N2 survival ranged from 1080% and unc-31 survival varied from 20-95% over 40-50 independent experiments of
48h anoxia in L4 worms. This made some data difficult to interpret, affected the results
of our neuropeptide screen and necessitated many independent experiments to reliably
conclude a biological effect. By and large, there was very little variation between the 3
technical replicates within an experiment, but the variability was substantial between
different experiments. We tried to address the source of this variability by accurately
staging animals at the same stage of L4 and positioning plates differently in the bags,
but we were unable to find a systematic factor that affected the range of survival.
However, there are some additional factors that may contribute to the variability that we
did not explore. Some of these are: precise volume of agar in plates, gentleness of
handling worms while placing them on plates, lot-to-lot variability in culture reagents,
small changes in the incubator environment and age of food on the plate.
We know that preconditioning worms to a stressor like a different diet, a different
growth temperature, or a short bout of anoxia enhances their survival under long term
anoxia (Dasgupta et al., 2007; LaRue and Padilla, 2011). Could it be that the source of
the variability comes from previous experience? Factors such as plate crowding, freshly
seeded food plates (‘younger’ OP50 vs ‘older’ OP50) and contamination in an earlier
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generation are some factors that can be readily controlled for in a systematic way.
Minimizing variability will be a huge benefit to ease of conducting and interpreting future
experiments.

Conclusion
A central theme bridging these two projects is that cell autonomous and nonautonomous factors regulate how an organism responds environmental stress and
disease. In the case of ALS, we demonstrate that decreasing metabolic rate by loss of
MC4R in the hypothalamus does not alter progression or outcome of ALS. However, we
do not know if there are cellular level changes to mitochondrial health, and if this is
different in the nervous system compared to muscles. In fALS, a mutation in a single
gene in all cells in the body affects mitochondrial health in many cells, whole body
metabolism but preferentially causes death of motor neurons. This points to cell
autonomous cellular damage. However, it remains to be determined what the source of
metabolic derangement in ALS is and how it relates to preferential death of motor
neurons. As suggested earlier, one potential mechanism is that a cell non-autonomous
factor, potentially released by energy starved neurons, signals to the rest of the body
and causes whole body hypermetabolism.
In the case of anoxic stress, we establish that loss of neuropeptide signaling is
beneficial to worms undergoing anoxia in a manner that is independent of many
established stress-resistance pathways. There is likely a group of neuropeptides, of
which nlp-40 is one, that regulates this response, and the neuropeptides are secreted
from the nervous system. This work demonstrates that soluble factors such as
neuropeptides can act cell non-autonomously to regulate organism level response to an
external stress.
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This work sheds light on the bidirectional role of metabolism in disease and
stress. Changes in metabolic rate can be an adaptive response to external stress, and
can be modulated to impact disease in sophisticated and specific ways.
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Lifespan of neuropeptide signaling mutants
In Chapter 3, the readout for all our experiments was survival of worms 24h after
recover from a 48h anoxic insult. However, this did not tell us anything about the biology
of the worms after this 24h post-anoxia window. We were curious to see if the various
neuropeptide signaling mutants we used in Chapter 3 had any differences in lifespan
pre- and post- anoxia. We placed L4 worms on plates supplemented with 5-Fluoro-2′deoxyuridine (FUdR) at a final concentration of 200uM, and measured their survival on
these plates either at baseline, or that of surviving worms after 48h of anoxia. FUdR is a
potent inhibitor of DNA synthesis, and was used here to prevent eggs laid by test
animals from hatching. In this manner, we avoided ‘contamination’ by progeny and
limited repeated handling and moving the test worms.
We found that all the neuropeptide mutants – egl-3 (ok979), egl-3 (gk238), egl-21
(n476), unc-31 (e928) – were significantly longer lived than the wild type line (Fig A1a).
Additionally, we measured the lifespan of surviving worms after the 48h anoxic insult,
and found that they continued to be longer-lived post anoxia (Fig. A1b). Interestingly the
lifespan of all lines, including N2, was higher post anoxia than that at baseline. Hence,
L4 staged neuropeptide mutant worms have significantly greater survival compared to
N2 after 48h anoxia (see Chapter 3), and the worms that survive anoxia have a greater
lifespan compared to N2 worms. Additionally, anoxia may act as a stressor that allows
worms that can survive the stress to have increased lifespan than those that do not
experience this stress.
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Fig. A1. Survival of anoxia tolerant neuropeptide mutants. Lifespan of mutants in egl-3, egl-21
and unc-31 are plotted against N2 lifespan a) at baseline and b) after 48h anoxia. Data are
analyzed using the Mantel-Cox test for survival curve comparisons. *p < 0.05, ***p < 0.001, ****p <
0.0001

‘Healthspan’ of neuropeptide signaling mutants
The lifespan of different worm lines tells us about how long they live, but does not
tell us about how well they live. We attempted to get a measure of worm ‘health’ post
anoxia. To do this, we scored anoxia-surviving worms 6 days after they were removed
from the anoxic biobags. We looked to see if worms had developed to adulthood, had
sexually matured and had normal locomotion on the plates. If they did, we scored these
as ‘healthy’. The worms that did not achieve these benchmarks were scored as
‘unhealthy’. These ‘unhealthy’ worms generally had one or more of the following
phenotypes, that did not change throughout their life: (i) they were much smaller than
normal adult worms, (ii) they had aberrant locomotion and stayed in the same spot on
the plate, (iii) they did not bear eggs, (iv) they appeared very pale, seemingly lacking the
characteristic dark color of adult worms due to fat deposits, (v) they had a ‘sheath’
105

surrounding the entire body, presumably the cuticle that they were unable to shed during
molting.
If the worms met any of these phenotypic criteria, we scored them as ‘unhealthy’.
Images of smaller, paler worms without eggs alongside ‘healthy’ worms are presented in
Fig. 2a-e. We also noticed that these worms tended to have shorter lifespan compared
to the ‘healthy’ worms on the same plate. These ‘unhealthy’ animals were present in all
the strains, including N2. However, there were strikingly fewer ‘unhealthy’ N2 worms
post-anoxia than all the other strains (Fig. A2f). This indicates that although a smaller
fraction of N2 worms survive the initial anoxic insult, those that do have a ‘healthier’
lifespan. Conversely, a higher proportion of neuropeptide signaling mutant worms
survive the initial anoxic insult, but many of them are ‘unhealthy’ after anoxia.
Additionally, the lifespan data in Fig A1b contains neuropeptide signaling mutants that
are both ‘healthy’ and ‘unhealthy’. This suggests that the anoxic insult generates two
populations of worms in these mutants, ones that are shorter-lived and sicker, and ones
that are very long-lived and healthier.
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Fig. A2. ‘Healthspan’ of anoxia-tolerant neuropeptide signaling mutants after
anoxia. a-e) Representative pictures of ‘healthy’ and ‘unhealthy’ surviving worms in N2
and anoxia-tolerant neuropeptide signaling mutants 6 days after 48h anoxia. f)
Quantification of percent ‘unhellthy’ worms in every genotype, alongside total number of
worms.
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Survival of egl-3 and unc-31 mutants after anoxia is additive
Since egl-3 is required for neuropeptide maturation and unc-31 is required for
neuropeptide secretion, we hypothesized that they are in the same genetic pathway,
where egl-3 acts upstream of unc-31. Compared to wild type worms, loss of function
mutants in each of these genes leads to increased survival after 48h anoxia in L4 worms
(Chapter 3). If they are in the same pathway, survival of egl-3;unc-31 double mutants
should not be any higher than either of the single mutants. On the other hand, if they
were in unrelated, parallel pathways, the combined survival of the double mutant would
be the sum of their individual survival phenotypes. In order to test this hypothesis, we
generated the double mutants and tested their survival after 54h anoxia. We chose a
higher anoxia duration because there was a ceiling effect of survival in these mutants at
48h, making it difficult to ascertain if they were truly in the same or parallel pathways.
To our surprise, we found that egl-3;unc-31 double mutants had significantly
greater survival compared to either of the single mutants (Fig. A3). This suggests that
egl-3 and unc-31 may act via different mechanisms, or in different cells, to confer a
survival benefit under anoxia. However, this requires further study. Further, it is worth
noting that survival of egl-3 and unc-31 mutants is much lower at 54h (30-40%) than at
48h (70-90%), and is not significantly different from N2. This suggests that there is a
limited window of anoxic exposure where loss of egl-3 and unc-31 activity is protective in
worms.
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Fig. A3. Survival of egl-3;unc-31 double mutants after anoxia. Worms were exposed to
54h anoxia, and allowed to recover for 24h before scoring live/dead worms (n = 4
independent experiments). Data were analyzed by one-way ANOVA with Tukey’s test for
multiple comparisons. ***p < 0.001.
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